+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 11139

Chapter 11139 contains a list of PDF Full Texts available from EurekaMag.

Kees, F.; Faerber, L.; Bucher, M.; Mair, G.; Moerike, K.; Grobecker, H., 2001:
Pharmacokinetics of therapeutic doses of tropisetron in healthy volunteers

Cordato, D.J.; Mather, L.E.; Gross, A.S.; Herkes, G.K., 1999:
Pharmacokinetics of thiopental enantiomers during and following prolonged high-dose therapy

Sandler, A.N.; Arlander, E.; Finucane, B.T.; Taddio, A.; Chan, V.; Milner, A.; Callahan-Enright, S.O.; Friedlander, M.; Muzyka, D., 1998:
Pharmacokinetics of three doses of epidural ropivacaine during hysterectomy and comparison with bupivacaine

Corot, C.; Violas, X.; Robert, P.; Port, M., 2000:
Pharmacokinetics of three gadolinium chelates with different molecular sizes shortly after intravenous injection in rabbits: relevance to MR angiography

Zhao, H.; Zheng, J.; Jiang, Z., 2001:
Pharmacokinetics of thrombin-like enzyme from venom of Agkistrodon halys ussuriensis Emelianov determined by ELISA in the rat

Rost, K.L.; Wierich, W.; Masayuki, F.; Tuthill, C.W.; Horwitz, D.L.; Herrmann, W.M., 1999:
Pharmacokinetics of thymosin alpha1 after subcutaneous injection of three different formulations in healthy volunteers

Timmer, C.J.; Verheul, H.A.M.; Doorstam, D.P., 2002:
Pharmacokinetics of tibolone in early and late postmenopausal women

Onyeji, C.O.; Tessier, P.R.; Nightingale, C.H.; Vallee, F.; Nicolau, D.P., 1999:
Pharmacokinetics of ticlopidine in the rabbit

Seiler, K.U.; Jähnchen, E.; Trenk, D.; Brennscheidt, U.; Heintz, B., 2001:
Pharmacokinetics of tilidine in terminal renal failure

Matsuura, K.; Shidawara, S.; Mano, H.; Irino, T.; Takashina, H., 1999:
Pharmacokinetics of tiopronin after oral administration in healthy volunteers

Geier, B.; Grossefeld, M.; Barbera, L.; Mumme, A., 2001:
Pharmacokinetics of tissue plasminogen activator in an isolated extracorporeal circuit

Beringer, P.M.; Vinks, A.A.; Jelliffe, R.W.; Shapiro, B.J., 2000:
Pharmacokinetics of tobramycin in adults with cystic fibrosis: implications for once-daily administration

Gross, A.S.; Bridge, S.; Shenfield, G.M., 1999:
Pharmacokinetics of tolbutamide in ethnic Chinese

Alyanakian, M.A.; Bernatowska, E.; Scherrmann, J.M.; Aucouturier, P.; Poplavsky, J.L., 2003:
Pharmacokinetics of total immunoglobulin G and immunoglobulin G subclasses in patients undergoing replacement therapy for primary immunodeficiency syndromes

Clewell, R.A.; Gearhart, J.M., 2002:
Pharmacokinetics of toxic chemicals in breast milk: use of PBPK models to predict infant exposure

Murthy, B.V.; Pandya, K.S.; Booker, P.D.; Murray, A.; Lintz, W.; Terlinden, R., 2000:
Pharmacokinetics of tramadol in children after i.v. or caudal epidural administration

Dowd, N.P.; Karski, J.M.; Cheng, D.C.; Carroll, J.A.; Lin, Y.; James, R.L.; Butterworth, J., 2002:
Pharmacokinetics of tranexamic acid during cardiopulmonary bypass

Wang, C.; Berman, N.; Longstreth, J.A.; Chuapoco, B.; Hull, L.; Steiner, B.; Faulkner, S.; Dudley, R.E.; Swerdloff, R.S., 2000:
Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study

Mao, Y.; Tao, X.; Lipsky, P.E., 1999:
Pharmacokinetics of triptolide. Development and application of a high performance liquid chromatographic method for quantitation of triptolide in plasma

Knowlton, P.W.; Loi, C.M.ng; Vassos, A.B.; Blum, R.A.; Brodfuehrer, J.I.; Randinitis, E.J.; Sedman, A.J.; Koup, J.R., 1999:
Pharmacokinetics of troglitazone in patients with renal insufficiency

Ott, P.; Ranek, L.; Young, M.A., 1998:
Pharmacokinetics of troglitazone, a PPAR-gamma agonist, in patients with hepatic insufficiency

Clara, L.O.; Biglia, M.A., 1999:
Pharmacokinetics of trovafloxacin: its clinical significance

Baraldo, M.; Pea, F.; Poz, D.; Furlanut, M., 2001:
Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients

Kowalski, C.; Roliński, Z.; Zań, R.; Wawron, W., 2002:
Pharmacokinetics of tylosin in broiler chickens

Tsai, T.H.; Hung, L.C.ien; Shum, A.Y.C.; Chen, C.F., 1999:
Pharmacokinetics of unbound chloramphenicol and its glucuronide in rat blood and brain tissue by microdialysis

Czock, D.; Scholle, C.; Rasche, F.Maximilian.; Schaarschmidt, D.; Keller, F., 2002:
Pharmacokinetics of valganciclovir and ganciclovir in renal impairment

Vasudev, K.; Das, S.; Goswami, U.; Tayal, G., 2001:
Pharmacokinetics of valproic acid in patients with bipolar disorder

Leidig, M., F.; Delles, C.; Kuchenbecker, C.; Lederle, R.-Ainer-Max; Weidinger, G.; Schmieder, R., E., 2001:
Pharmacokinetics of valsartan in hypertensive patients on long-term haemodialysis

Heinemann, G.; Fichtl, B.; Vogt, W., 2003:
Pharmacokinetics of vanadium in humans after intravenous administration of a vanadium containing albumin solution

Kitzes-Cohen, R.; Farin, D.; Piva, G.; Ivry, S.; Sharony, R.; Amar, R.; Uretzky, G., 2000:
Pharmacokinetics of vancomycin administered as prophylaxis before cardiac surgery

Sawicki, W.; Janicki, S., 2002:
Pharmacokinetics of verapamil and its metabolite norverapamil from a buccal drug formulation

Sawicki, Wieslaw, 2002:
Pharmacokinetics of verapamil and norverapamil from controlled release floating pellets in humans

Solans, C.; Bregante, M.A.; Aramayona, J.J.; Fraile, L.J.; Garcia, M.A., 2000:
Pharmacokinetics of verapamil in New Zealand white rabbits during ontogeny

Groninger, E.; Meeuwsen-de Boar, T.; Koopmans, P.; Uges, D.; Sluiter, W.; Veerman, A.; Kamps, W.; de Graaf, S., 2002:
Pharmacokinetics of vincristine monotherapy in childhood acute lymphoblastic leukemia

Thuermann, P.A.; Sonnenburg, C.; Valentova, K.; Gregora, E.; Freischlaeger, F.; Lissner, R., 2001:
Pharmacokinetics of viral antibodies after administration of intravenous immunoglobulin in patients with chronic lymphocytic leukaemia or multiple myeloma

Moodley, D.; Pillay, K.; Naidoo, K.; Moodley, J.; Johnson, M.A.; Moore, K.H.; Mudd, P.N.; Pakes, G.E., 2001:
Pharmacokinetics of zidovudine and lamivudine in neonates following coadministration of oral doses every 12 hours

Gopinath, D.; Ravi, D.; Karwa, R.; Rao, B.R.; Shashank, A.; Rambhau, D., 2002:
Pharmacokinetics of zidovudine following intravenous bolus administration of a novel niosome preparation devoid of cholesterol

Wattanagoon, Y.; Na Bangchang, K.; Hoggard, P.G.; Khoo, S.H.; Gibbons, S.E.; Phiboonbhanakit, D.; Karbwang, J.; Back, D.J., 2000:
Pharmacokinetics of zidovudine phosphorylation in human immunodeficiency virus-positive thai patients and healthy volunteers

Kawada, K.; Itoh, S.; Kusaka, T.; Isobe, K.; Ishii, M., 2002:
Pharmacokinetics of zonisamide in perinatal period

Depre, M.; Ehrich, E.; Van Hecken, A.; D.L.peleire, I.; Dallob, A.; Wong, P.; Porras, A.; Gertz, B.J.; D.S.hepper, P.J., 2000:
Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans

Kuchimanchi, K.R.; Udata, C.; Johnston, T.P.; Mitra, A.K., 2000:
Pharmacokinetics, biliary excretion, and tissue distribution of novel anti-HIV agents, cosalane and dihydrocosalane, in Sprague-Dawley rats

Ruiz Garcia, A.; Bermejo, M.; Merino, V.; Sanchez Castano, G.; Freixas, J.; Garrigues, T.M., 1999:
Pharmacokinetics, bioavailability and absorption of flumequine in the rat

Vaishnaw, A.K.; Tenhoor, C.N., 2002:
Pharmacokinetics, biologic activity, and tolerability of alefacept by intravenous and intramuscular administration

Angst, M.S.; Dyck, J.B.; Azarnoff, D.L.; Goldblum, R.; Ho, B.; Gfroerer, T.; Linton, E.A.; Glynn, B.P.; Shafer, S.L., 1998:
Pharmacokinetics, cortisol release, and hemodynamics after intravenous and subcutaneous injection of human corticotropin-releasing factor in humans

Yates, R.; Nairn, K.; Dixon, R.; Kemp, J.V.; Dane, A.L., 2002:
Pharmacokinetics, dose proportionality, and tolerability of single and repeat doses of a nasal spray formulation of zolmitriptan in healthy volunteers

Dobs, A.S.; Meikle, A.W.; Arver, S.; Sanders, S.W.; Caramelli, K.E.; Mazer, N.A., 1999:
Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men

Lehtoranta, K.; Tainio, H.; Lukkari-Lax, E.; Hakonen, T.; Tammela, T.L.J., 2002:
Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity

Issar, M.; Singh, S.K.; Mishra, B.; Gupta, R.C., 2003:
Pharmacokinetics, in-situ absorption and protein binding studies of a new neuroleptic agent centbutindole in rats

Wroblewski, V., J.; Mccloud, C.; Davis, K.; Manetta, J.; Micanovic, R.; Witcher, D., R., 2003:
Pharmacokinetics, metabolic stability, and subcutaneous bioavailability of a genetically engineered analog of DcR3, flint (DcR3(R218Q)), in cynomolgus monkeys and mice

Kajbaf, M.; Barnaby, R.J.; Bottacini, M.; Bertolotti, L.; Ismail, I.M.; Cholerton, T.J.; Pellegatti, M., 2003:
Pharmacokinetics, metabolism and excretion of the glycine antagonist GV150526A in rat and dog

Slatter, J.G.; Stalker, D.J.; Feenstra, K.L.; Welshman, I.R.; Bruss, J.B.; Sams, J.P.; Johnson, M.G.; Sanders, P.E.; Hauer, M.J.; Fagerness, P.E.; Stryd, R.P.; Peng, G.W.; Shobe, E.M., 2001:
Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of (14C)linezolid to healthy human subjects

Liu Xiu Wen; Yang Kui; L.Q.u Jun; Tang Zhong Ming; Wen, L.Q.ng; Guo Shao Ming, 2000:
Pharmacokinetics, peripheral platelet counts and anti-thrombopoietin-antibodies after multi-dosing of recombinant human thrombopoietin in macaca mulatta

Wahlander, K.; Lapidus, L.; Olsson, C.G.stav; Thuresson, A.; Eriksson, U.G.; Larson, G.; Eriksson, H., 2002:
Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis

Khor, S.P.; McCarthy, K.; DuPont, M.; Murray, K.; Timony, G., 2000:
Pharmacokinetics, pharmacodynamics, allometry, and dose selection of rPSGL-Ig for phase I trial

Koch, M.; Niemeyer, G.; Patel, I.; Light, S.; Nashan, B., 2002:
Pharmacokinetics, pharmacodynamics, and immunodynamics of daclizumab in a two-dose regimen in liver transplantation

Hansen, R.J.; Balthasar, J.P., 2001:
Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb/IIIa monoclonal antibody (7E3) in the rat: a quantitative rat model of immune thrombocytopenic purpura

Drover, D.; Lemmens, H.; Naidu, S.; Cevallos, W.; Darwish, M.; Stanski, D., 2000:
Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem

Zannikos, P.N.; Rohatagi, S.; Jensen, B.K.; DePhillips, S.L.; Massignon, D.; Calic, F.; Sibille, M.; Kirkesseli, S., 2000:
Pharmacokinetics, pharmacodynamics, and safety of a platelet GPIIb/IIIa antagonist, RGD891, following intravenous administration in healthy male volunteers

Sola, M.C.; Christensen, R.D.; Hutson, A.D.; Tarantal, A.F., 2000:
Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys

Rohatagi, S.; Calic, F.; Harding, N.; Ozoux, M.L.; Bouriot, J.P.; Kirkesseli, S.; DeLeij, L.; Jensen, B.K., 2000:
Pharmacokinetics, pharmacodynamics, and safety of inhaled cyclosporin A (ADI628) after single and repeated administration in healthy male and female subjects and asthmatic patients

Chen, T.; Miller, T.F.; Prasad, P.; Lee, J.; Krauss, J.; Miscik, K.; Kalafsky, G.; Mcleod, J.E., 2000:
Pharmacokinetics, pharmacodynamics, and safety of microencapsulated octreotide acetate in healthy subjects

Milton, K.Ashley.; Scott, N.R.; Allen, M.J.; Abel, S.; Jenkins, V.C.; James, G.C.; Rance, D.J.; Eve, M.D., 2002:
Pharmacokinetics, pharmacodynamics, and safety of the 5-HT(1B/1D) agonist eletriptan following intravenous and oral administration

Skoner, David, P., 2000:
Pharmacokinetics, pharmacodynamics, and the delivery of pediatric bronchodilator therapy

Stratton, Charles, W., 1998:
Pharmacokinetics, pharmacodynamics, and tolerability profile of clinafloxacn

Russell, T.; Stolz, M.; Weir, S., 1998:
Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fedofenadine hydrochloride in healthy male volunteers

Shirahata, A.; Fukutake, K.; Takamatsu, J.; Shima, M.; Yoshioka, A., 2000:
Pharmacokinetics, prophylactic effects, and safety of a new recombinant FVIII formulated with sucrose (BAY 14-2222) in Japanese patients with hemophilia A

Baisley, K.J.; Boyce, M.J.; Bukofzer, S.; Pradhan, R.; Warrington, S.J., 2002:
Pharmacokinetics, safety and tolerability of three dosage regimens of buccal adhesive testosterone tablets in healthy men suppressed with leuprorelin

Dickson, T.Z.; Zagrobelny, J.; Lin, C.C.; Ritter, M.A.; Snavely, D.; Ramjit, D.; Shahinfar, S.; Lo, M-Wai., 2003:
Pharmacokinetics, safety, and antihypertensive efficacy of losartan in combination with hydrochlorothiazide in hypertensive patients with renal impairment

Barst, R.J.; Ivy, D.; Dingemanse, J.; Widlitz, A.; Schmitt, K.; Doran, A.; Bingaman, D.; Nguyen, N.; Gaitonde, M.; Van Giersbergen, P.L.M., 2003:
Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension

Weinblatt, M.E.; Kremer, J.M.; Coblyn, J.S.; Maier, A.L.; Helfgott, S.M.; Morrell, M.; Byrne, V.M.; Kaymakcian, M.V.; Strand, V., 1999:
Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis

Shah, A.; Woodruff, M.; Agarwal, V.; Liu, P.; Sundaresan, P., 2001:
Pharmacokinetics, safety, and tolerability of BAY 12-9566 and nonsteroidal anti-inflammatory agents (naproxen, ibuprofen) during coadministration in patients with osteoarthritis

Zannikos, P.N.; Baybutt, R.I.; Boutouyrie, B.X.; Shah, B.; Hunt, T.L.; Jensen, B.K., 1999:
Pharmacokinetics, safety, and tolerability of single intravenous infusions of an adenosine agonist, AMP 579, in healthy male volunteers

Kim, G.B.; Kim, Y.G.; Kim, S.H.; Park, H.G.; Jew, S.S.; Lee, M.G., 2000:
Pharmacokinetics, skin absorption, stability, blood partition, and protein binding of AS 2-006A, a new wound healing agent

Wang, Z.J.n; He, Y.Y.ng; Huang, C.G.o; Huang, J.S.eng; Huang, Y.C.i; An, J.Y.; Gu, Y.; Jiang, L.J.n, 1999:
Pharmacokinetics, tissue distribution and photodynamic therapy efficacy of liposomal-delivered hypocrellin A, a potential photosensitizer for tumor therapy

Egorin, M., J.; Lagattuta, T., F.; Hamburger, D., R.; Covey, J., M.; White, K., D.; Musser, S., M.; Eiseman, J., L., 2002:
Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats

Paulson, S.K.; Zhang, J.Y.; Breau, A.P.; Hribar, J.D.; Liu, N.W.; Jessen, S.M.; Lawal, Y.M.; Cogburn, J.N.; Gresk, C.J.; Markos, C.S.; Maziasz, T.J.; Schoenhard, G.L.; Burton, E.G., 2000:
Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats

Lazarus, H.M.; O'riordan, M.A.n; Creger, R.J.; Myers, C.M.; Blumer, J.L.; Reed, M.D., 1999:
Pharmacokinetics, tolerability and efficacy of bolus-dose vs continuous-infusion granisetron in the prevention of vomiting in patients undergoing haematopoietic stem-cell transplantation: A randomised, double-blind evaluation

McConville, B.J.; Arvanitis, L.A.; Thyrum, P.T.; Yeh, C.; Wilkinson, L.A.; Chaney, R.O.; Foster, K.D.; Sorter, M.T.; Friedman, L.M.; Brown, K.L.; Heubi, J.E., 2000:
Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders

Slatter, J.G.; Adams, L.A.; Bush, E.C.; Chiba, K.; Daley-Yates, P.T.; Feenstra, K.L.; Koike, S.; Ozawa, N.; Peng, G.W.; Sams, J.P.; Schuette, M.R.; Yamazaki, S., 2002:
Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog

Ambrose, P.G.; Bhavnani, S.M.; Jones, R.N., 2003:
Pharmacokinetics-pharmacodynamics of cefepime and piperacillin-tazobactam against Escherichia coli and Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: report from the ARREST program

Jayaram, R.; Gaonkar, S.; Kaur, P.; Suresh, B.L.; Mahesh, B.N.; Jayashree, R.; Nandi, V.; Bharat, S.; Shandil, R.K.; Kantharaj, E.; Balasubramanian, V., 2003:
Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis

Silbaugh, S.A.; Stengel, P.W.; Cockerham, S.L.; Froelich, L.L.; Bendele, A.M.; Spaethe, S.M.; Sofia, M.J.; Sawyer, J.S.ott; Jackson, W.T., 2000:
Pharmacologic actions of the second generation leukotriene B4 receptor antagonist LY293111: In vivo pulmonary studies

Susic, D.; Varagic, J.; Frohlich, E.D., 1999:
Pharmacologic agents on cardiovascular mass, coronary dynamics and collagen in aged spontaneously hypertensive rats

Foster, D., R.; Rybak, M., J., 1999:
Pharmacologic and bacteriologic properties of SCH-27899 (Ziracin), an investigational antibiotic from the everninomicin family

Homanics, G.E.; Quinlan, J.J.; Firestone, L.L., 1999:
Pharmacologic and behavioral responses of inbred C57BL/6J and strain 129/SvJ mouse lines

Foote, M.; Colowick, A.; Goodkin, D.A., 2003:
Pharmacologic and cytokine treatment of commonly encountered anemias

Kowey, P.R.; Yan, G.X.n; Winkel, E.; Kao, W., 2003:
Pharmacologic and nonpharmacologic options to maintain sinus rhythm: Guideline-based and new approaches

Ereshefsky, L., 1999:
Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic

Schousboe, Arne, 1999:
Pharmacologic and therapeutic aspects of the developmentally regulated expression of GABAA and GABAB receptors: Cerebellar granule cells as a model system

Melin, A.M.; Perromat, A.; Déléris, G., 1999:
Pharmacologic application of FTIR spectroscopy: effect of ascorbic acid-induced free radicals on Deinococcus radiodurans

Melin, A.M.; Perromat, A.; Déléris, G., 2000:
Pharmacologic application of fourier transform IR spectroscopy: in vivo toxicity of carbon tetrachloride on rat liver

Perromat, A.; Melin, A.M.rie; Deleris, G., 2001:
Pharmacologic application of Fourier transform infrared spectroscopy: The in vivo toxic effect of carrageenan

Anton, R.F., 2001:
Pharmacologic approaches to the management of alcoholism

Ramelet, A.A., 2000 :
Pharmacologic aspects of a phlebotropic drug in CVI-associated edema

Katz, Philip, O., 2000:
Pharmacologic basis of pantoprazole dosing

Tsikouris, J.P.; Cox, C.D., 2003:
Pharmacologic blockade of the renin-angiotensin system: Vascular benefits beyond commonly understood pharmacologic actions

Wijffels, M.C.E.F.; Dorland, R.; Allessie, M.A., 1999:
Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: A comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol

DeVane, C.L., 2000:
Pharmacologic characteristics of ideal antidepressants in the 21st century

Fletcher, C.V.; Brundage, R.C.; Remmel, R.P.; Page, L.M.; Weller, D.; Calles, N.R.; Simon, C.; Kline, M.W., 2000:
Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapy

Tanaka, Y.; Kaneko, H.; Tanaka, H.; Shigenobu, K., 1999:
Pharmacologic characteristics of non-prostanoid, non-nitric oxide mediated and endothelium-dependent relaxation of guinea-pig aorta in response to substance P

Grover, G.J.; D'Alonzo, A.J.; Garlid, K.D.; Bajgar, R.; Lodge, N.J.; Sleph, P.G.; Darbenzio, R.B.; Hess, T.A.; Smith, M.A.; Paucek, P.; Atwal, K.S., 2001:
Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity

Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T., 1999:
Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent

Iwasaki, T.; Mihara, S.; Shimamura, T.; Kawakami, M.; Masui, M.; Hayasaki-Kajiwara, Y.; Naya, N.; Ninomiya, M.; Fujimoto, M.; Nakajima, M., 2001:
Pharmacologic characterization of S-1255, a highly potent and orally active endothelin A receptor antagonist

Gul, H.; Yildiz, O.; Simsek, A.; Balkan, M.; Ersoz, N.; Cetiner, S.; Isimer, A.; Sen, D., 2003:
Pharmacologic characterization of contractile serotonergic receptors in human isolated mesenteric artery

Schachter, E.N.; Zuskin, E.; Rienzi, N.; Goswami, S.; Maayani, S., 1998:
Pharmacologic characterization of latex extracts by isolated guinea pig tracheal tissue

Lam, F.F., 2000:
Pharmacologic characterization of receptor types mediating coronary vasodilator actions of sensory neuropeptides in the guinea pig

Sloand, E.; Kim, S.; Maciejewski, J.; Young, N., 2001:
Pharmacologic concentrations of granulocyte-colony stimulating factor affect cytokine expression by lymphocytes

Fletcher, C.V., 1999:
Pharmacologic considerations for therapeutic success with antiretroviral agents

Sloand, E.M.; Kim, S.; Maciejewski, J.P.; Van Rhee, F.; Chaudhuri, A.; Barrett, J.; Young, N.S., 2000:
Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo

Belayet, H.M.; Kanayama, N.; Khatun, S.; Asahina, T.; Okada, Y.; Kitamura, K.; Kobayashi, T.; Terao, T., 2000:
Pharmacologic doses of interleukin 8 suppositories induce follicular maturation in rabbits

Yamagata, Y.; Yuasa, Y.; Yamamoto, K.; Okamoto, K.; Igari, Y.; Iga, K.; Ogawa, Y., 2000:
Pharmacologic effect of recombinant human IFN-alpha, continuously released from a matrix prepared from a polyglycerol ester of fatty acids, on 2',5'-oligoadenylate synthetase activity in murine liver

Thaulow, E., 1999:
Pharmacologic effects of calcium channel blockers on restenosis

Schachter, E.N.; Zuskin, E.; Rienzi, N.; Goswami, S., 1999:
Pharmacologic effects of cocoa and rye flour extracts on isolated guinea pig trachea

Lutton, J.D.; Jiang, S.; Drummond, G.S.; Abraham, N.G.; Levere, R.D.; Kappas, A., 1999:
Pharmacologic effects of the red blood cell substitutes cross-linked and non-cross-linked hemoglobins on hematopoiesis in rabbits

Schachter, E.Neil.; Zuskin, E.; Goswami, S.; Castranova, V.; Siegel, P.; Whitmer, M.; Gadgil, A., 2003:
Pharmacologic effects of tobacco dust extract on isolated Guinea pig trachea

Baudet, S.; Noireaud, J., 1999:
Pharmacologic evaluation of isometric contraction-relaxation coupling indexes in rabbit ventricular muscle

Gu, M.; Takada, Y.; Fukunaga, K.; Ishiguro, S.; Taniguchi, H.; Seino, K.; Yuzawa, K.; Otsuka, M.; Todoroki, T.; Fukao, K., 2000:
Pharmacologic graft protection without donor pretreatment in liver transplantation from non-heart-beating donors

Demers, G.William.; Johnson, D.E.; Tsai, V.; Wen, S-Fen.; Quijano, E.; Machemer, T.; Philopena, J.; Ramachandra, M.; Howe, J.A.; Shabram, P.; Ralston, R.; Engler, H., 2003:
Pharmacologic indicators of antitumor efficacy for oncolytic virotherapy

LaPlaca, M.C.; Zhang, J.; Raghupathi, R.; Li, J.H.; Smith, F.; Bareyre, F.M.; Snyder, S.H.; Graham, D.I.; McIntosh, T.K., 2001:
Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats

Pacher, P.; Liaudet, L.; Mabley, J., G.; Komjati, K.; Szabo, C., 2002:
Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure

Szekeres, M.; Dézsi, L.; Nádasy, G.L.; Kaley, G.; Koller, A., 2001:
Pharmacologic inhomogeneity between the reactivity of intramural coronary arteries and arterioles

Yoon, M.Ha.; Choi, J.Il., 2003:
Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test

Koedel, U.; Bayerlein, I.; Paul, R.; Sporer, B.; Pfister, H.W., 2000:
Pharmacologic interference with NF-kappaB activation attenuates central nervous system complications in experimental Pneumococcal meningitis

Hollenberg, N.K., 1999:
Pharmacologic interruption of the renin-angiotensin system and the kidney: differential responses to angiotensin-converting enzyme and renin inhibition

Kinuya, S.; Yokoyama, K.; Kawashima, A.; Hiramatsu, T.; Konishi, S.; Shuke, N.; Watanabe, N.; Takayama, T.; Michigishi, T.; Tonami, N., 2000:
Pharmacologic intervention with angiotensin II and kininase inhibitor enhanced efficacy of radioimmunotherapy in human colon cancer xenografts

Rojas Fernandez, C.H.; Eng, M.; Allie, N.D., 2003:
Pharmacologic management by clinical pharmacists of behavioral and psychological symptoms of dementia in nursing home residents: Results from a pilot study

Flynn, B.L., 1999:
Pharmacologic management of Alzheimer disease, Part I: Hormonal and emerging investigational drug therapies

Flynn, B.L.; Ranno, A.E., 1999:
Pharmacologic management of Alzheimer disease, Part II: Antioxidants, antihypertensives, and ergoloid derivatives

Snow, V.; Weiss, K.; Wall, E.M.; Mottur-Pilson, C., 2002 :
Pharmacologic management of acute attacks of migraine and prevention of migraine headache

Levy, Samuel, 2001:
Pharmacologic management of atrial fibrillation: Current therapeutic strategies

Flynn, Joseph, T., 2002:
Pharmacologic management of childhood hypertension: Current status, future challenges

Vivian, E.M.; Rubinstein, G.B.een, 2002:
Pharmacologic management of diabetic nephropathy

Schneider, L.S., 1999:
Pharmacologic management of psychosis in dementia

Hunninghake, Donald, B., 1999:
Pharmacologic management of triglycerides

Yu, C.; Krystal, G.; Varticovksi, L.; McKinstry, R.; Rahmani, M.; Dent, P.; Grant, S., 2002:
Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells

Csukai, M.; Mochly-Rosen, D., 1999:
Pharmacologic modulation of protein kinase C isozymes: the role of RACKs and subcellular localisation

Binah, O., 2001:
Pharmacologic modulation of the immune interaction between cytotoxic lymphocytes and ventricular myocytes

Meddahi, S.; Bara, L.; Fessi, H.; Samama, M.M., 2000:
Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin

Rangan, G.K.; Wang, Y.; Harris, D.C., 2001:
Pharmacologic modulators of nitric oxide exacerbate tubulointerstitial inflammation in proteinuric rats

Stevens, R.D.; Burri, H.; Tramer, M.R., 2003:
Pharmacologic myocardial protection in patients undergoing noncardiac surgery: A quantitative systematic review

Ruscoe, J.E.; Rosario, L.A.; Wang, T.; Gaté, L.; Arifoglu, P.; Wolf, C.R.; Henderson, C.J.; Ronai, Z.; Tew, K.D., 2001:
Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways

Andersson, K.E.ik; Hedlund, P., 2002:
Pharmacologic perspective on the physiology of the lower urinary tract

Monroe, V.S.ephen; Kerensky, R.A.; Rivera, E.; Smith, K.M.; Pepine, C.J., 2003:
Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes

Yabe, K.; Ishishita, H.; Tanonaka, K.; Takeo, S., 1998:
Pharmacologic preconditioning induced by beta-adrenergic stimulation is mediated by activation of protein kinase C

Lee, T.M.ng; Su, S.F.ng; Chou, T.F.u; Tsai, C.H.r, 2002:
Pharmacologic preconditioning of estrogen by activation of the myocardial adenosine triphosphate-sensitive potassium channel in patients undergoing coronary angioplasty

Lipton, Richard, B., 1999:
Pharmacologic profile and clinical efficacy of rizatriptan

Tashiro, M.; Hirohata, Y.; Kihara, Y.; Akiyama, T.; Otsuki, M., 1999:
Pharmacologic profile of TS-951, a new benzodiazepine derivative cholecystokinin-receptor antagonist, in in vitro isolated rat pancreatic acini

Maillard, M.P.; Rossat, J.; Nussberger, J.; Ramis, J.; Pontes, C.; Burnier, M.; Brunner, H.R., 2000:
Pharmacologic profile of UR-7247, an orally active angiotensin II AT1 receptor antagonist, in healthy volunteers

Sweet, R.A.; Pollock, B.G.; Mulsant, B.H.; Rosen, J.; Sorisio, D.; Kirshner, M.; Henteleff, R.; DeMichele, M.A., 2000:
Pharmacologic profile of perphenazine's metabolites

Green, J.R.; Rogers, M.J., 2002:
Pharmacologic profile of zoledronic acid: A highly potent inhibitor of bone resorption

Ebisu, H.; Nishikawa, M.; Tanaka, M.; Okazoe, T.; Morizawa, Y.; Shinyama, H.; Nakamura, N., 1999:
Pharmacologic profiles of GA0113, a novel quinoline derivative angiotensin II AT1-receptor antagonist

Nihei, O.K.; de Carvalho, A.C.; Savino, W.; Alves, L.A., 2000:
Pharmacologic properties of P(2Z)/P2X(7 )receptor characterized in murine dendritic cells: role on the induction of apoptosis

Schachter, E.N.; Zuskin, E.; Rienzi, N.; Goswami, S.; Castranova, V.; Whitmer, M.; Siegel, P., 2001:
Pharmacologic properties of brewery dust extracts in vitro

Bheekha Escura, R.; Chance, S.R.; Langdon, J.M.; Macglashan, D.W.Jr.; Macdonald, S.M., 1999:
Pharmacologic regulation of histamine release by the human recombinant histamine-releasing factor

Jutte, S.B.; Sprague, J.E., 2000:
Pharmacologic regulation of the renin-angiotensin system: Physiologic and pathologic effects

Bhardwaj, R.; Hadley, M.E.; Dorr, R.T.; Dvorakova, K.; Brooks, C.; Blanchard, J., 2000:
Pharmacologic response of a controlled-release PLGA formulation for the alpha-melanocyte stimulating hormone analog, Melanotan-I

Dunning, B.E.; Deacon, R.; Gutierrez, C.; Paladini, S.; Valentin, M.A.; Foley, J.E., 2003:
Pharmacologic restoration of the early insulin response in pre-diabetic monkeys controls mealtime glucose excursions without peripheral hyperinsulinaemia

Caramia, M.D.; Palmieri, M.G.; Desiato, M.T.; Iani, C.; Scalise, A.; Telera, S.; Bernardi, G., 2000:
Pharmacologic reversal of cortical hyperexcitability in patients with ALS

Womer, D.E.; Shannon, H.E., 2000:
Pharmacologic reversal of pertussis toxin-induced thermal allodynia in mice

Nakayama, H.; Yamamoto, Y.; Kume, M.; Yamagami, K.; Yamamoto, H.; Kimoto, S.; Ishikawa, Y.; Ozaki, N.; Shimahara, Y.; Yamaoka, Y., 1999:
Pharmacologic stimulation of adenosine A2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers

Friedman, J.I.; Temporini, H.; Davis, K.L., 1999:
Pharmacologic strategies for augmenting cognitive performance in schizophrenia

Rickels, K.; DeMartinis, N.; Rynn, M.; Mandos, L., 1999:
Pharmacologic strategies for discontinuing benzodiazepine treatment

Vivian, E.M.; Thompson, M.A., 2000:
Pharmacologic strategies for treating gastroesophageal reflux disease

Kim, C.; Kwok, Y.S.; Heagerty, P.; Redberg, R., 2001:
Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis

Rivers, R.J., 1999:
Pharmacologic study of muscarinic receptor subtypes and arteriolar dilations: a comparison of conducted and local responses

Van den Brande, J.; Nannan Panday, V.R.; Hoekman, K.; Rosing, H.; Huijskes, R.V.; Verheijen, R.H.; Beijnen, J.H.; Vermorken, J.B., 2001:
Pharmacologic study of paclitaxel administered with or without the cytoprotective agent amifostine, and given as a single agent or in combination with epirubicin and cisplatin in patients with advanced solid tumors

Curci, J.A.; Petrinec, D.; Liao, S.; Golub, L.M.; Thompson, R.W., 1998:
Pharmacologic suppression of experimental abdominal aortic aneurysms: A comparison of doxycycline and four chemically modified tetracyclines

Trautnitz, M.; Pehlivanli, S.; Behr, J.; Schwaiblmair, M.; Ueberfuhr, P.; Meiser, B.; Von-Scheidt, W., 1999:
Pharmacologic testing of the reversibility of an increased pulmonary vascular resistance before heart transplantation with prostaglandin I2 (prostacyclin)

Cockcroft, D.W., 1999:
Pharmacologic therapy for asthma: overview and historical perspective

DeGraff, A.C., 2002:
Pharmacologic therapy for nicotine addiction

Klein, L.; O'connor, C.M.; Gattis, W.A.; Zampino, M.; D.L.ca, L.; Vitarelli, A.; Fedele, F.; Gheorghiade, M., 2003:
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: Review of trials and practical considerations

Hiatt, W.R., 2002:
Pharmacologic therapy for peripheral arterial disease and claudication

Defronzo, Ralph, A., 1999:
Pharmacologic therapy for type 2 diabetes mellitus

Kasim, S.; Jinnah, H.A., 2002:
Pharmacologic thresholds for self-injurious behavior in a genetic mouse model of Lesch-Nyhan disease

Snow, V.; Lascher, S.; Mottur Pilson, C., 2000:
Pharmacologic treatment of acute major depression and dysthymia

Salzman, C.; Goldenberg, I.; Bruce, S.E.; Keller, M.B., 2001:
Pharmacologic treatment of anxiety disorders in 1989 versus 1996: results from the Harvard/Brown anxiety disorders research program

Carter, W.P.; Hudson, J.I.; Lalonde, J.K.; Pindyck, L.; McElroy, S.L.; Pope, H.G., 2003:
Pharmacologic treatment of binge eating disorder

Faulkner, M.A.; Hilleman, D.E., 2003:
Pharmacologic treatment of chronic obstructive pulmonary disease: Past, present, and future

Wisner, K.L.; Gelenberg, A.J.; Leonard, H.; Zarin, D.; Frank, E., 1999:
Pharmacologic treatment of depression during pregnancy

Spooner, J.J.; Lapane, K.L.; Hume, A.L.; Mor, V.; Gambassi, G., 2001:
Pharmacologic treatment of diabetes in long-term care

Koller, W.C.; Hristova, A.; Brin, M., 2000:
Pharmacologic treatment of essential tremor

DeQuardo, J.R., 1998:
Pharmacologic treatment of first-episode schizophrenia: early intervention is key to outcome

O'Connor, P.G.; Fiellin, D.A., 2000:
Pharmacologic treatment of heroin-dependent patients

Levitsky, A.M.; Owens, N.J., 1999:
Pharmacologic treatment of hypersexuality and paraphilias in nursing home residents

Siegel, D.; Lopez, J.; Meier, J., 1998:
Pharmacologic treatment of hypertension in the Department of Veterans Affairs during 1995 and 1996

Goode, P.S.; Burgio, K.L., 1997:
Pharmacologic treatment of lower urinary tract dysfunction in geriatric patients

Sindrup, S.H.; Jensen, T.S., 2000:
Pharmacologic treatment of pain in polyneuropathy

Kane, John, M., 1999:
Pharmacologic treatment of schizophrenia

Jailwala, J.; Imperiale, T.F.; Kroenke, K., 2000:
Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials

Przyklenk, K., 2001:
Pharmacologic treatment of the stunned myocardium: the concepts and the challenges

Yamashita, K.; Upadhyay, S.; Osada, M.; Hoque, M.O.; Xiao, Y.; Mori, M.; Sato, F.; Meltzer, S.J.; Sidransky, D., 2002:
Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma

Van Gelder, I.C.; Tuinenburg, A.E.; Schoonderwoerd, B.S.; Tieleman, R.G.; Crijns, H.J.G.M., 1999:
Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation

Eskurza, I.; Seals, D.R.; Desouza, C.A.; Tanaka, H., 2001:
Pharmacologic versus flow-mediated assessments of peripheral vascular endothelial vasodilatory function in humans

Coates, P.Toby.H.; Colvin, B.L.; Kaneko, K.; Taner, T.; Thomson, A.W., 2003 :
Pharmacologic, biologic, and genetic engineering approaches to potentiation of donor-derived dendritic cell tolerogenicity

Song, J.C.; White, C.M.chael, 2000:
Pharmacologic, pharmacokinetic, and therapeutic differences among angiotensin II receptor antagonists

Zhang, Z.; Andersen, A.; Grondin, R.; Barber, T.; Avison, R.; Gerhardt, G.; Gash, D., 2001:
Pharmacological MRI mapping of age-associated changes in basal ganglia circuitry of awake rhesus monkeys

Cho, T.S.on; Lee, S.M.e; Lee, E.B.ng; Cho, S.I.; Kim, Y.K.e; Shin, D.H.e; Park, D.K.u, 1999:
Pharmacological action of New Wonbang Woohwangchungsimwon Pill on cerebral ischemia and central nervous system

Yerneni, L.Kumar.; Jayaraman, S., 2003:
Pharmacological action of high doses of melatonin on B16 murine melanoma cells depends on cell number at time of exposure

Cuzzocrea, S.; Reiter, R.J., 2001:
Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury

Zhao Huiying; Shimokawa, H., 1999:
Pharmacological actions and chronic vascular effects of Nomega-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthase

Shimizu, I.; Kawashima, K.; Ishii, D.; Oku, S.; Kohayakawa, H.; Oka, M., 2001:
Pharmacological actions of AH-9700 on micturition reflex in anesthetized rats

Cho, T.S.on; Lee, S.M.e; Kim, N.D.o; Huh, I.H.i; Ann, H.S.o; Kwon, K.I.; Park, S.K.; Shim, S.H.; Shin, D.H.e; Park, D.K.u, 1999:
Pharmacological actions of New Wonbang Woohwangchungsimwon Pill on cardiovascular system

Reavill, C.; Taylor, S.G.; Wood, M.D.; Ashmeade, T.; Austin, N.E.; Avenell, K.Y.; Boyfield, I.; Branch, C.L.; Cilia, J.; Coldwell, M.C.; Hadley, M.S.; Hunter, A.J.; Jeffrey, P.; Jewitt, F.; Johnson, C.N.; Jones, D.N.; Medhurst, A.D.; Middlemiss, D.N.; Nash, D.J.; Riley, G.J.; Routledge, C.; Stemp, G.; Thewlis, K.M.; Trail, B.; Vong, A.K.; Hagan, J.J., 2000:
Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A

Galbiati, E.; Caruso, P.Lorenza.; Amari, G.; Armani, E.; Ghirardi, S.; Delcanale, M.; Civelli, M., 2002:
Pharmacological actions of a novel, potent, tissue-selective benzopyran estrogen

Yang, S.R.ng; Yao Ming Hui, 2000:
Pharmacological actions of buflomedil on peripheral isolated blood vessels in rats

Satoh, H.; Tsuchida, K., 1999:
Pharmacological actions of monovalent ionophores on spontaneously beating rabbit sino-atrial nodal cells

Liao, G.S.; Li, X.B.; Zhang, C.Y.; Shu, Y.Y.; Tang, S.X., 2001:
Pharmacological actions of nerve growth factor-transferrin conjugate on the central nervous system

Mao, L.; Wang, J.Q., 2000:
Pharmacological activation of nociceptin receptors in the nucleus tractus solitarius inhibits baroreceptor reflex in pentobarbital-anesthetized rats

Shim, J.Y.ung; Lee, Y.S.l; Jung, S.H.on; Choi, H.S.ok; Shin, K.H.un; Kim, Y.S.ik, 2002:
Pharmacological activities of a new glycosaminoglycan, acharan sulfate isolated from the giant African snail Achatina fulica

Piek, T.; L.C.rronc, H.; Gobbo, M.; Hue, B.; Mantel, P.; Rocchi, R., 1999:
Pharmacological activities of cyclic bradykinin analogues

Lichtman, A.H.; Hawkins, E.Gregory.; Griffin, G.; Cravatt, B.F., 2002:
Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo

Zanoli, P.; Rivasi, M.; Baraldi, C.; Baraldi, M., 2002:
Pharmacological activity of hyperforin acetate in rats

Devyatkina, T.A.; Lutsenko, R.V.; Vazhnichaya, E.M., 2003:
Pharmacological activity of mexidol in rats with stress-induced liver damage

Hatziantoniou, S.; Rallis, M.; Demetzos, C.; Papaioannou, G.T., 2000:
Pharmacological activity of natural lipids on a skin barrier disruption model

Val'dman, E.A., 2000:
Pharmacological activity of the new adamantane derivative: A potential antiparkinsonian drug-assessed upon subchronic administration

Zwissler, B., 1999:
Pharmacological adjuvants in the treatment of ARDS

Samanci, A.; Yi, Q.; Fagerberg, J.; Strigard, K.; Smith, G.; Ruden, U.; Wahren, B.; Mellstedt, H., 1998:
Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen

Breuner, C.W.; Jennings, D.H.; Moore, M.C.; Orchinik, M., 2000:
Pharmacological adrenalectomy with mitotane

Tasker, R.C., 1999:
Pharmacological advance in the treatment of acute brain injury

Schoepp, D.D.; Jane, D.E.; Monn, J.A., 1999:
Pharmacological agents acting at subtypes of metabotropic glutamate receptors

Myhrer, T.; Skymoen, L.Rune.; Aas, Pål., 2003:
Pharmacological agents, hippocampal EEG, and anticonvulsant effects on soman-induced seizures in rats

Rossignol, S.; Giroux, N.; Chau, C.; Marcoux, J.; Brustein, E.; Reader, T.A., 2001:
Pharmacological aids to locomotor training after spinal injury in the cat

Gidener, S.; Gümüştekin, M.; Kirkali, Z., 1999:
Pharmacological analysis of 5-hydroxytryptamine effects on human isolated ureter

Gazi, L.; Wurch, T.; Lopéz-Giménez, J.F.; Pauwels, P.J.; Strange, P.G., 2003:
Pharmacological analysis of a dopamine D(2Short):G(alphao) fusion protein expressed in Sf9 cells

Horinouchi, T.; Koike, K., 1999:
Pharmacological analysis of atypical beta-adrenoceptors in the guinea pig gastric fundus using the beta(3)-adrenoceptor antagonist bupranolol

Fossetta, J.; Jackson, J.; Deno, G.; Fan, X.; Du, X.Karen.; Bober, L.; Soudé-Bermejo, A.; de Bouteiller, O.; Caux, C.; Lunn, C.; Lundell, D.; Palmer, R.Kyle., 2003:
Pharmacological analysis of calcium responses mediated by the human A3 adenosine receptor in monocyte-derived dendritic cells and recombinant cells

Van Den Broek, R.W.M.; Vandenbrink, A.M.assen; D.V.ies, R.; Bogers, A.J.J.C.; Stegmann, A.P.A.; Avezaat, C.J.; Saxena, P.R., 2000:
Pharmacological analysis of contractile effects of eletriptan and sumatriptan on human isolated blood vessels

Campbell, J.M.; Gilmore, D.P.; Russell, D.; Growney, C.A.; Favor, G.; Kennedy, A.K.; Davies, R.W.; Payne, A.P.; Stone, T.W., 2000:
Pharmacological analysis of extracellular dopamine and metabolites in the striatum of conscious as/agu rats, mutants with locomotor disorder

Chiba, S.; Yang, X.P., 2002:
Pharmacological analysis of functional neurovascular transmission in canine splenic arteries: Role of neuropeptide Y

Alves Rodrigues, A.; Lemstra, S.; Vollinga, R.C.; Menge, W.M.P.B.; Timmerman, H.; Leurs, R., 2001:
Pharmacological analysis of immepip and imetit homologues. Further evidence for histamine H3 receptor heterogeneity?

Matsuno, H., 2000:
Pharmacological analysis of integrin function: inhibition of vascular stenosis and identification of a novel antiplatelet substance

Hiraoka, Y.; Taniguchi, T.; Oshita, M.; Muramatsu, I., 2000:
Pharmacological analysis of neurogenic, sympathetic responses mediated through alpha-1-, alpha-2-adrenergic and purinergic receptors in the dog saphenous vein

Yoshida, M.; Inadome, A.; Murakami, S., 2003:
Pharmacological analysis of neurotransmitters contributing to lower urinary tract function

Xiao, Y.Q.n; Minami, K.I.hi; Mue, S.; Ohuchi, K., 1998:
Pharmacological analysis of protein kinases responsible for chemotaxis of rat peritoneal neutrophils

Fietta, A.M.; Morosini, M.; Meloni, F.; Bianco, A.Marone.; Pozzi, E., 2002:
Pharmacological analysis of signal transduction pathways required for mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes

Christopoulos, A.; Parsons, A.M.; El-Fakahany, E.E., 1999:
Pharmacological analysis of the novel mode of interaction between xanomeline and the M1 muscarinic acetylcholine receptor

Xu, L.; Ball, S.L.; Alexander, K.R.; Peachey, N.S., 2003:
Pharmacological analysis of the rat cone electroretinogram

Wurch, T.; Junquero, D.; Delhon, A.; Pauwels, J., 2002:
Pharmacological analysis of wild-type alpha, gamma and delta subtypes of the human peroxisome proliferator-activated receptor

Tsukimi, Y.; Amagase, K.; Ogawa, T.; Tomita, K.; Okabe, S.; Ono, A., 2001:
Pharmacological analysis of wine-stimulated gastric acid secretion in dogs

Tamiz, A.P.; Bandyopadhyay, B.C.; Zhang, J.; Flippen Anderson, J.L.; Zhang, M.; Wang, C.Z.; Johnson, K.M.; Tella, S.; Kozikowski, A.P., 2001:
Pharmacological and behavioral analysis of the effects of some bivalent ligand-based monoamine reuptake inhibitors

Miller, K.A.; Witkin, J.M.; Ungard, J.T.; Gasior, M., 2000:
Pharmacological and behavioral characterization of cocaine-kindled seizures in mice

Grazzi, L.; D'amico, D.; Leone, M.; Moschiano, F.; Bussone, G., 1998:
Pharmacological and behavioral treatment of pediatric migraine and tension-type headache

Fitzgerald, L.W.; Patterson, J.P.; Conklin, D.S.; Horlick, R.; Largent, B.L., 1998:
Pharmacological and biochemical characterization of a recombinant human galanin GALR1 receptor: agonist character of chimeric galanin peptides

Abraham, G.; Kottke, C.; Dhein, S.; Ungemach, F.R.pert, 2003:
Pharmacological and biochemical characterization of the beta-adrenergic signal transduction pathway in different segments of the respiratory tract

Liu, L.; Warner, F.J.; Conlon, J.M.chael; Burcher, E., 1999:
Pharmacological and biochemical investigation of receptors for the toad gut tachykinin peptide, bufokinin, in its species of origin

Bardou, M.; Cortijo, J.; Loustalot, C.; Taylor, S.; Perales Marin, A.; Mercier, F.J.; Dumas, M.; Deneux Tharaux, C.; Frydman, R.; Morcillo, E.J.; Advenier, C., 1999:
Pharmacological and biochemical study on the effects of selective phosphodiesterase inhibitors on human term myometrium

Macchi, B.; Mastino, A., 2002:
Pharmacological and biological aspects of basic research on nucleoside-based reverse transcriptase inhibitors

Albengres, E., 2000:
Pharmacological and biological basis of drug hypersensitivities

Brevi, S.; de Curtis, M.; Magistretti, J., 2001:
Pharmacological and biophysical characterization of voltage-gated calcium currents in the endopiriform nucleus of the guinea pig

Bo, X.; Jiang, L-Hua.; Wilson, H.L.; Kim, M.; Burnstock, G.; Surprenant, A.; North, R.Alan., 2003:
Pharmacological and biophysical properties of the human P2X5 receptor

Brauns, O.; Liepold, T.; Radulovic, J.; Spiess, J., 2001:
Pharmacological and chemical properties of astressin, antisauvagine-30 and alpha-helCRF: significance for behavioral experiments

Fujiwara, M.; Liou, S.-Yuh, 2002:
Pharmacological and clinical profile of lamivudine (Zefix(R))

Tanaka, M., 2002:
Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent

Nishio, S.; Kurumatani, H., 2001:
Pharmacological and clinical properties of beraprost sodium, orally active prostacyclin analogue

Uchida, M.; Nakahara, H., 2000:
Pharmacological and clinical properties of cetirizine hydrochloride

Okiyama, M.; Kawashima, H.; Fukunishi, S., 2002:
Pharmacological and clinical properties of didanosine (VIDEX), a nucleoside reverse transcriptase inhibitor

Akiyoshi, M.; Shigeoka, T.; Torii, S.; Maki, E.; Enomoto, S.; Takahashi, H.; Hirano, F., 2002:
Pharmacological and clinical properties of levocabastine hydrochloride (eye drop and nasal spray), a selective H1 antagonist

Loran, O.B.; Pushkar, D.Y.; Avetisyan, M.M.; Rasner, P.I., 2001:
Pharmacological and cost-effect grounds for use of categel and categel F in urological practice

Taylor, R.E., 2003:
Pharmacological and cultural considerations in alcohol treatment clinical trials: issues in clinical research related to race and ethnicity

Rodríguez-Franco, F.; Sainz, A.; Tesouro, M.A.; Amusategui, I.; Cortes, O., 1999:
Pharmacological and dietary treatment of canine malabsorption syndrome: a retrospective study of 17 clinical cases

Heisel, A.; Jung, J.; Schieffer, H., 2000:
Pharmacological and electrical therapy of supraventricular tachyarrhythmias

Sugiyama, A.; Satoh, Y.; Ishida, Y.; Yoneyama, M.; Yoshida, H.; Hashimoto, K., 2002:
Pharmacological and electrophysiological characterization of junctional rhythm during radiofrequency catheter ablation of the atrioventricular node: possible involvement of neurotransmitters from autonomic nervous system

Besecke, L.M.; Diaz, G.J.; Segreti, J.A.; Mohning, K.M.; Cybulski, V.A.; Rao, M.; Bush, E.N.; Randolph, J.T.; Waid, P.L.; Haviv, F.; Wegner, C.D.; Greer, J., 2001:
Pharmacological and endocrine characterization of A-198401, an orally active GnRH antagonist, in intact and castrate male rat models

Spooren, W., P.J.M.; Schoeffter, P.; Gasparini, F.; Kuhn, R.; Gentsch, C., 2002:
Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608)

Hyder, S.M.; Chiappetta, C.; Stancel, G.M., 2001 :
Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells

Spealman, R.D.; Barrett Larimore, R.L.; Rowlett, J.K.; Platt, D.M.; Khroyan, T.V., 1999:
Pharmacological and environmental determinants of relapse to cocaine-seeking behavior

Patel, S.; Chapman, K.L.; Marston, D.; Hutson, P.H.; Ragan, C.I.n, 2003:
Pharmacological and functional characterisation of dopamine D4 receptors in the rat retina

Ragheb, F.; Molina Holgado, E.; Cui, Q.L.ng; Khorchid, A.; Liu, H.N.ng; Larocca, J.N.; Almazan, G., 2001:
Pharmacological and functional characterization of muscarinic receptor subtypes in developing oligodendrocytes

Erickson, R.P.; Garver, W.S.; Camargo, F.; Hossain, G.S.; Heidenreich, R.A., 2000:
Pharmacological and genetic modifications of somatic cholesterol do not substantially alter the course of CNS disease in Niemann-Pick C mice

Hu, H.; Sato, T.; Seharaseyon, J.; Liu, Y.; Johns, D.C.; O'Rourke, B.; Marbán, E., 1999:
Pharmacological and histochemical distinctions between molecularly defined sarcolemmal KATP channels and native cardiac mitochondrial KATP channels

Morais, M.M.; Belarmino-Filho, J.N.; Brito, G.A.; Ribeiro, R.A., 1999:
Pharmacological and histopathological study of cyclophosphamide-induced hemorrhagic cystitis - comparison of the effects of dexamethasone and Mesna

Takasaki, I.; Andoh, T.; Nitta, M.; Takahata, H.; Nemoto, H.; Shiraki, K.; Nojima, H.; Kuraishi, Y., 2000:
Pharmacological and immunohistochemical characterization of a mouse model of acute herpetic pain

McConnell, E.J.; White, G.W.; Brokaw, J.J.; Raess, B.U., 2000:
Pharmacological and immunohistochemical characterization of calmodulin-stimulated (Ca(2+)+Mg(2+))-ATPase in cultured porcine aortic endothelial cells

Medhurst, A.D.; Jennings, C.A.; Robbins, M.J.; Davis, R.P.; Ellis, C.; Winborn, K.Y.; Lawrie, K.W.M.; Hervieu, G.; Riley, G.; Bolaky, J.E.; Herrity, N.C.; Murdock, P.; Darker, J.G., 2003:
Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin

Loubani, M.; Galinanes, M., 2002:
Pharmacological and ischemic preconditioning of the human myocardium: MitoKATP channels are upstream and p38MAPK is downstream of PKC

Buckner, S.A.; Milicic, I.; Daza, A.; Davis Taber, R.; Scott, V.E.S.; Sullivan, J.P.; Brioni, J.D., 2000:
Pharmacological and molecular analysis of ATP-sensitive K+ channels in the pig and human detrusor

Sharif, N.A.; Senchyna, M.; Xu, S.X., 2002:
Pharmacological and molecular biological (RT-PCR) characterization of functional TP prostanoid receptors in immortalized human non-pigmented ciliary epithelial cells

Okamoto-Koizumi, T.; Takeda, M.; Komeyama, T.; Hatano, A.; Tamaki, M.; Mizusawa, T.; Tsutsui, T.; Obara, K.; Tomita, Y.; Arai, K.; Takahashi, K., 1999:
Pharmacological and molecular biological evidence for ETA endothelin receptor subtype mediating mechanical responses in the detrusor smooth muscle of the human urinary bladder

Carignani, C.; Roncarati, R.; Rimini, R.; Terstappen, G.C., 2002:
Pharmacological and molecular characterisation of SK3 channels in the TE671 human medulloblastoma cell line

Contesse, V.; Lenglet, S.; Grumolato, L.; Anouar, Y.; Lihrmann, I.; Lefebvre, H.; Delarue, C.; Vaudry, H., 1999:
Pharmacological and molecular characterization of 5-hydroxytryptamine(7) receptors in the rat adrenal gland

Miller, T.R.; Davis Taber, R.; Molinari, E.J.; Whiteaker, K.L.; Monteggia, L.M.; Scott, V.E.S.; Brioni, J.D.; Sullivan, J.P.; Gopalakrishnan, M., 1999:
Pharmacological and molecular characterization of ATP-sensitive K+ channels in the TE671 human medulloblastoma cell line

Morley, P.; MacLean, S.; Gendron, T.F.; Small, D.L.; Tremblay, R.; Durkin, J.P.; Mealing, G., 2000:
Pharmacological and molecular characterization of glutamate receptors in the MIN6 pancreatic beta-cell line

Preiksaitis, H.G.; Krysiak, P.S.; Chrones, T.; Rajgopal, V.; Laurier, L.G., 2000:
Pharmacological and molecular characterization of muscarinic receptor subtypes in human esophageal smooth muscle

Zanassi, P.; Paolillo, M.; Montecucco, A.; Avvedimento, E.V.; Schinelli, S., 1999:
Pharmacological and molecular evidence for dopamine D1 receptor expression by striatal astrocytes in culture

Scatton, B.; Sanger, D.J., 2000:
Pharmacological and molecular targets in the search for novel antipsychotics

Whiteaker, P.; Marks, M.J.; Grady, S.R.; Lu, Y.; Picciotto, M.R.; Changeux, J.P.erre; Collins, A.C., 2000:
Pharmacological and null mutation approaches reveal nicotinic receptor diversity

Mamidi, R.N.V.S.; Mullangi, R.; Kota, J.; Bhamidipati, R.; Khan, A.A.; Katneni, K.; Datla, S.; Singh, S.K.; Rao, K.Y.; Rao, C.Seshagiri.; Srinivas, N.R.; Rajagopalan, R., 2002:
Pharmacological and pharmacokinetic evaluation of celecoxib prodrugs in rats

Tokuyama, S.; Takahashi, M., 2001:
Pharmacological and physiological effects of ginseng on actions induced by opioids and psychostimulants

Sullivan, S.K.; McGrath, D.A.; Grigoriadis, D.; Bacon, K.B., 1999:
Pharmacological and signaling analysis of human chemokine receptor CCR-7 stably expressed in HEK-293 cells: high-affinity binding of recombinant ligands MIP-3beta and SLC stimulates multiple signaling cascades

Tanaka, M.; Banba, M.; Joko, A.; Moriyama, Y., 2001:
Pharmacological and therapeutic properties of lafutidine (stogar and protecadin), a novel histamine H2 receptor antagonist with gastroprotective activity

Geroni, C.; Ripamonti, M.; Arrigoni, C.; Fiorentini, F.; Capolongo, L.; Moneta, D.; Marchini, S.; Della Torre, P.; Albanese, C.; Lamparelli, M.G.; Ciomei, M.; Rossi, R.; Caruso, M., 2001:
Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agent

Strunecka, A.; Patocka, J., 1999:
Pharmacological and toxicological effects of aluminofluoride complexes

Grandadam, F.; Lluel, P.; Palea, S.; Martin, D.J., 1999:
Pharmacological and urodynamic changes in rat urinary bladder function after multiple pregnancies

He, Q.; Riley, R., T.; Sharma, R., P., 2002:
Pharmacological antagonism of fumonisin B1 cytotoxicity in porcine renal epithelial cells (LLC-PK1): A model for reducing fumonisin-induced nephrotoxicity in vivo

Chang, F.C.T.; Hoffman, B.E.; Debus, S., 2002:
Pharmacological antagonism of lethal effects induced by O-isobutyl S-(2-(diethylamino)ethyl)methylphosphonothioate

Whitworth, C., A.; Rybak, L., P.; Kemp, R.; Spence, S., 2001:
Pharmacological antagonism of the slow-activating delayed rectifying potassium channel (IKs) has no effect on cochlear structure and function in vivo

Swank, Michael, W., 2000:
Pharmacological antagonism of tyrosine kinases and MAP kinase in brainstem blocks taste aversion learning in mice

Nielsen, S.; Møller, N.; Christiansen, J.S.; Jørgensen, J.O., 2001:
Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure

Bakhtiar, R.; Ochiai, E.I.hiro, 1999:
Pharmacological applications of inorganic complexes

Famulari, A.L.; D'abraccio, G.; Gonzalez, S.; Bartolome, E.; Bagg, E.; Dominguez, R.O.; Fernandez Castelo, S.S.; Balcarce, P.; Abiusi, G.; Vila, J.F.; Rotta Escalante, R.; Rugiero, M.; Reich, E., 1999:
Pharmacological approach of agitated behavioral disorders in elderly people. Clinical trial to determine therapeutical availability

Goldstein, L.B., 1999:
Pharmacological approach to functional reorganization: the role of norepinephrine

Brasseur, L.; Desgieux, P.; Guirimand, F., 1999:
Pharmacological approach to pain treatment: An update

Liebetanz, D.; Nitsche, M.A.; Tergau, F.; Paulus, W., 2002:
Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability

Whittle, B.J., 1999:
Pharmacological approach to the prevention of non-steroidal anti-inflammatory drug-induced gastropathy

Bellantonio, S.; Kuchel, G., A., 2002:
Pharmacological approaches to cognitive deficits and incontinence (1899-2002): Progress in geriatric care

Harvey, S.A.; Jensen, K.O.; Elmore, L.W.; Holt, S.E., 2002:
Pharmacological approaches to defining the role of chaperones in aging and prostate cancer progression

Diener, H.Ch., 2003:
Pharmacological approaches to migraine

Supattapone, S.; Nishina, K.; Rees, J.R., 2002:
Pharmacological approaches to prion research

Kovesi, T.; Royston, D., 2003:
Pharmacological approaches to reducing allogeneic blood exposure

Andraus, M.H.; D.S.queira, M.E.isa Pereira, B., 2000:
Pharmacological aspects of butorphanol

Thomas, J.A., 2002:
Pharmacological aspects of erectile dysfunction

D.V.ies, P.; Villalon, C.M.; Saxena, P.R., 1999:
Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy

Miller, V.M.; Rud, K.S.; Gloviczki, P., 2000:
Pharmacological assessment of adrenergic receptors in human varicose veins

Birrell, M.A.; McCluskie, K.; Haddad, E-Bdaoui.; Battram, C.H.; Webber, S.E.; Foster, M.L.; Yacoub, M.H.; Belvisi, M.G., 2003:
Pharmacological assessment of the nitric-oxide synthase isoform involved in eosinophilic inflammation in a rat model of sephadex-induced airway inflammation

Herdon, H.J.; Godfrey, F.M.; Brown, A.M.; Coulton, S.; Evans, J.R.; Cairns, W.J., 2001:
Pharmacological assessment of the role of the glycine transporter GlyT-1 in mediating high-affinity glycine uptake by rat cerebral cortex and cerebellum synaptosomes

Howard, Matthew Owen, 2001:
Pharmacological aversion treatment of alcohol dependence. I. Production and prediction of conditioned alcohol aversion

Lotfi, K.; Mansson, E.; Chandra, J.; Wang, Y.; Xu, D.; Knaust, E.; Spasokoukotskaja, T.; Liliemark, E.; Eriksson, S.; Albertioni, F., 2001:
Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide

Kakuda, T.N.; Page, L.M.; Anderson, P.L.; Henry, K.; Schacker, T.W.; Rhame, F.S.; Acosta, E.P.; Brundage, R.C.; Fletcher, C.V., 2000:
Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir

Dalla Volta, S., 1999:
Pharmacological basis of antiplatelet drugs in acute myocardial infarction: Focus on triflusal

Secondo, A.; Taglialatela, M.; Cataldi, M.; Giorgio, G.; Valore, M.; Di Renzo, G.; Annunziato, L., 2000:
Pharmacological blockade of ERG K(+) channels and Ca(2+) influx through store-operated channels exerts opposite effects on intracellular Ca(2+) oscillations in pituitary GH(3) cells

Remizov, I.N.; Beregovaya, T.V.; Groisman, S.D.; Purnyn, E.E.; Harchenko, M.M.; Gmiro, V.E.; Skok, V.I., 1999:
Pharmacological blockade of cardiac and stomach enteric ganglia by means of newly synthesized parasympatholytic

D'onofrio, M.; Arcella, A.; Bruno, V.; Ngomba, R.T.; Battaglia, G.; Lombari, V.; Ragona, G.; Calogero, A.; Nicoletti, F., 2003:
Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells

Rupniak, N.M.J.; Carlson, E.C.; Harrison, T.; Oates, B.; Seward, E.; Owen, S.; De-Felipe, C.; Hunt, S.; Wheeldon, A., 2000:
Pharmacological blockade or genetic deletion of substance P (NK1) receptors attenuates neonatal vocalisation in guinea-pigs and mice

Heinrich, R.; Wenzel, B.; Elsner, N., 2001:
Pharmacological brain stimulation releases elaborate stridulatory behaviour in gomphocerine grasshoppers: Conclusions for the organization of the central nervous control

Wiley, J.L.; Bühler, K.G.; Lavecchia, K.L.; Johnson, K.M., 2003:
Pharmacological challenge reveals long-term effects of perinatal phencyclidine on delayed spatial alternation in rats

Noorwez, S.M.; Kuksa, V.; Imanishi, Y.; Zhu, L.; Filipek, Sławomir.; Palczewski, K.; Kaushal, S., 2003:
Pharmacological chaperone-mediated in vivo folding and stabilization of the P23H-opsin mutant associated with autosomal dominant retinitis pigmentosa

Morello, J.P.; Salahpour, A.; Laperrière, A.; Bernier, V.; Arthus, M.F.; Lonergan, M.; Petäjä-Repo, U.; Angers, S.; Morin, D.; Bichet, D.G.; Bouvier, M., 2000:
Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants

Rizzi, A.; Salis, M.-Bonaria; Ciccocioppo, R.; Marzola, G.; Bigoni, R.; Guerrini, R.; Massi, M.; Madeddu, P.; Salvadori, S.; Regoli, D.; Calo, G., 2002:
Pharmacological characterisation of ((pX)Phe4)nociceptin(1-13)NH2 analogues. 2. In vivo studies

Bigoni, R.; Rizzi, D.; Rizzi, A.; Camarda, V.; Guerrini, R.; Lambert, D., G.; Hashiba, E.; Berger, H.; Salvadori, S.; Regoli, D.; Calo, G., 2002:
Pharmacological characterisation of ((pX)Phe4)nociceptin(1-13)amide analogues. 1. In vitro studies

Markstein, R.; Matsumoto, M.; Kohler, C.; Togashi, H.; Yoshioka, M.; Hoyer, D., 1999:
Pharmacological characterisation of 5-HT receptors positively coupled to adenylyl cyclase in the rat hippocampus

Hirst, W.D.; Babbs, A.J.; Green, A.; Minton, J.A.L.; Shaw, T.E.; Wise, A.; Rice, S.Q.; Pangalos, M.N.; Price, G.W., 2003:
Pharmacological characterisation of a cell line expressing GABAB1b and GABAB2 receptor subunits

Beer, M.S.; Heald, M.A.ne; Mcalister, G.; Stanton, J.A., 1998:
Pharmacological characterisation of a cloned dogs 5-HT1B receptor cell line

Hansen, B.S.; Raun, K.; Nielsen, K.K.; Johansen, P.B.; Hansen, T.K.; Peschke, B.; Lau, J.; Andersen, P.H.; Ankersen, M., 1999:
Pharmacological characterisation of a new oral GH secretagogue, NN703

Riediger, T.; Schmid, H.A.; Young, A.A.; Simon, E., 1999:
Pharmacological characterisation of amylin-related peptides activating subfornical organ neurones

Mello, S.B.V.; Guzzo, M.Luiza.; Lisboa, L.Filipe.Santiago.; Farsky, S.H.P., 2002:
Pharmacological characterisation of arthritis induced by Bothrops jararaca venom in rabbits: a positive cross talk between bradykinin, nitric oxide and prostaglandin E2

Lay, L.; Angus, J.A.; Wright, C.E., 2000:
Pharmacological characterisation of cannabinoid CB1 receptors in the rat and mouse

Ihenetu, K.; Molleman, A.; Parsons, M.; Whelan, C., 2003:
Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells

Earl, C.D.; Sautter, J.; Xie, J.; Kruk, Z.L.; Kupsch, A.; Oertel, W.H., 1998:
Pharmacological characterisation of dopamine overflow in the striatum of the normal and MPTP-treated common marmoset, studied in vivo using fast cyclic voltammetry, nomifensine and sulpiride

Hamilton, C.A.; Williams, R.; Pathi, V.; Berg, G.; McArthur, K.; McPhaden, A.R.; Reid, J.L.; Dominiczak, A.F., 1999:
Pharmacological characterisation of endothelium-dependent relaxation in human radial artery: comparison with internal thoracic artery

Jerman, J.C.; Brough, S.J.; Gager, T.; Wood, M.; Coldwell, M.C.; Smart, D.; Middlemiss, D.N., 2001:
Pharmacological characterisation of human 5-HT2 receptor subtypes

Camarda, V.; Rizzi, A.; Calo, G.; Wirth, K.; Regoli, D., 2002:
Pharmacological characterisation of novel kinin B2 receptor ligands

Sak, K.; Samuel, K.; Kelve, M.; Webb, T.E., 2001:
Pharmacological characterisation of pyrimidinoceptor responses in NG108-15 cells

Van Der Weyden, L.; Adams, D.J.; Luttrell, B.M.; Conigrave, A.D.; Morris, M.B., 2000:
Pharmacological characterisation of the P2Y11 receptor in stably transfected haematological cell lines

Chong, L.K.; Chess-Williams, R.; Peachell, P.T., 2002:
Pharmacological characterisation of the beta-adrenoceptor expressed by human lung mast cells

Stenfors, C.; Yu, H.; Ross, S.B., 2001:
Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram

Sundquist, S.; Modiri, A.R.za; Nilsson, B.M.; Hacksell, U.; Gillberg, P.G.ran; Nilvebrant, L., 2000:
Pharmacological characterisation of the enantiomers of BM-5, a muscarinic partial agonist with opposed enantioselectivity between affinity and efficacy

Rizzi, A.; Rizzi, C.; Amadesi, S.; Calo', G.; Varani, K.; Inamura, N.; Regoli, D., 1999:
Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: An in vitro study on human, rabbit and pig vascular B2 receptors

Nunn, C.; Feuerbach, D.; Lin, X.; Peter, R.; Hoyer, D., 2002:
Pharmacological characterisation of the goldfish somatostatin sst5 receptor

Terstappen, G.C.; Pula, G.; Carignani, C.; Chen, M.X.; Roncarati, R., 2001:
Pharmacological characterisation of the human small conductance calcium-activated potassium channel hSK3 reveals sensitivity to tricyclic antidepressants and antipsychotic phenothiazines

Pintér, E.; Helyes, Z.; Németh, József.; Pórszász, Róbert.; Pethö, Gábor.; Thán, Márta.; Kéri, Görgy.; Horváth, Aó.; Jakab, Bázs.; Szolcsányi, János., 2002:
Pharmacological characterisation of the somatostatin analogue TT-232: effects on neurogenic and non-neurogenic inflammation and neuropathic hyperalgesia

Erichsen, H.K.rstein; Blackburn Munro, G., 2002:
Pharmacological characterisation of the spared nerve injury model of neuropathic pain

Ohta, H.; Satomi, T.; Suzuki, J.; Ikemoto, F.; Nishikibe, M., 1999:
Pharmacological characteristics and clinical application of losartan, an orally active AT1 angiotensin II receptor antagonist

Toscano, E.; Romero, G.; Oset, C.; Del Rio, J., 1999:
Pharmacological characteristics and regulation of 5-HT receptor-stimulated phosphoinositide hydrolysis in the rat spinal cord

Tsushima, H.; Mori, M.; Fujiwara, N.; Moriyama, A., 2003:
Pharmacological characteristics of bombesin receptor mediating hypothermia in the central nervous system of rats

Liu, S.-Hong; Shan, L.-Mei; Wang, H., 2002:
Pharmacological characteristics of novel putative purinoceptors in vascular endothelium

Ohno, Y., 2000:
Pharmacological characteristics of perospirone hydrochloride, a novel antipsychotic agent

Shan, L.M.i; Wang, H., 2002:
Pharmacological characteristics of the endothelial target for acetylcholine induced vascular relaxation

Wang, Hai, 2003:
Pharmacological characteristics of the novel antihypertensive drug, iptakalim hydrochloride, and its molecular mechanisms

Heinen, A.; Brüss, M.; Bönisch, H.; Göthert, M.; Molderings, G.J., 2003:
Pharmacological characteristics of the specific transporter for the endogenous cell growth inhibitor agmatine in six tumor cell lines

Schaffhauser, Hé.; Rowe, B.A.; Morales, S.; Chavez-Noriega, L.E.; Yin, R.; Jachec, C.; Rao, S.P.; Bain, G.; Pinkerton, A.B.; Vernier, J-Michel.; Bristow, L.J.; Varney, M.A.; Daggett, L.P., 2003:
Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2

Panneels, V.; Eroglu, C.; Cronet, P.; Sinning, I., 2003:
Pharmacological characterization and immunoaffinity purification of metabotropic glutamate receptor from Drosophila overexpressed in Sf9 cells

Camey, K.U.; Velarde, D.T.; Sanchez, E.F., 2002:
Pharmacological characterization and neutralization of the venoms used in the production of Bothropic antivenom in Brazil

Inazu, M.; Takeda, H.; Ikoshi, H.; Sugisawa, M.; Uchida, Y.; Matsumiya, T., 2001:
Pharmacological characterization and visualization of the glial serotonin transporter

Davis, T.L.; Sharif, N.A., 2000:
Pharmacological characterization of (3H)-prostaglandin E2 binding to the cloned human EP4 prostanoid receptor

Schober, D.A.; Gackenheimer, S.L.; Heiman, M.L.; Gehlert, D.R., 2000:
Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors

Hancock, A.A.; Buckner, S.A.; Brune, M.E.; Katwala, S.; Milicic, I.; Ireland, L.M.; Morse, P.A.; Knepper, S.M.; Meyer, M.D.; Chapple, C.R.; Chess Williams, R.; Noble, A.J.; Williams, M.; Kerwin, J.F.Jr, 1998:
Pharmacological characterization of A-131701, a novel alpha1-adrenoceptor antagonist selective for alpha1A- and alpha1D- compared to alpha1B-adrenoceptors

Merkel, L.; Rojas, C.J.; Jarvis, M.F.; Cox, B.F.; Fink, C.; Smits, G.J.; Spada, A.P.; Perrone, M.H.; Clark, K.L., 1998:
Pharmacological characterization of AMP 579, a novel adenosine A1/A2 receptor agonist and cardioprotective

Marie, N.; Landemore, G.; Debout, C.; Jauzac, P.; Allouche, S., 2003:
Pharmacological characterization of AR-M1000390 at human delta opioid receptors

Beebe, J.S.; Jani, J.P.; Knauth, E.; Goodwin, P.; Higdon, C.; Rossi, A.Marie.; Emerson, E.; Finkelstein, M.; Floyd, E.; Harriman, S.; Atherton, J.; Hillerman, S.; Soderstrom, C.; Kou, K.; Gant, T.; Noe, M.C.; Foster, B.; Rastinejad, F.; Marx, M.A.; Schaeffer, T.; Whalen, P.M.; Roberts, W.Gregory., 2003:
Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy

Hwang, T.L.ng; Yeh, Y.A.; Chern, J.W.ng; Teng, C.M.ng, 2000:
Pharmacological characterization of EK112, a new combined angiotensin II and thromboxane A2 receptor antagonist

Barocelli, E.; Ballabeni, V.; Chiavarini, M.; Bertoni, S.; Mor, M.; Plazzi, P.V.; Bordi, F.; Impicciatore, M., 2000:
Pharmacological characterization of H3 receptor antagonists with imidazole, thioimidazole and thioimidazoline polar groups in the side chain

Lee, B.H.; Lee, S.H.; Jung, Y.S.ok; Seo, H.W.n; Yoo, S.E.n; Shin, H.S.p, 1999:
Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog

Kobayashi, M.; Takeda, K.; Murata, S.; Kojima, M.; Akahane, M.; Inoue, Y.; Kitamura, K.; Kawarabayashi, T., 2001:
Pharmacological characterization of KUR-1246, a selective uterine relaxant

Lee, C.H.; Oh, J.I.; Park, H.D.; Kim, H.J.; Park, T.K.; Kim, J.S.; Hong, C.Y.; Lee, S.J.; Ahn, K.H.; Kim, Y.Z., 1999:
Pharmacological characterization of LB50016, N-(4-amino)butyl 3-phenylpyrrolidine derivative, as a new 5-HT1A receptor agonist

Wesołowska, A.; Paluchowska, M.H.; Gołembiowska, K.; Chojnacka-Wójcik, E., 2003:
Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats

Jarvis, M.F.; Kowaluk, E.A., 2001:
Pharmacological characterization of P2X3 homomeric and heteromeric channels in nociceptive signaling and behavior

Iwasaki, T.; Mihara, S.; Shimamura, T.; Kawakami, M.; Hayasaki-Kajiwara, Y.; Naya, N.; Fujimoto, M.; Nakajima, M., 1999:
Pharmacological characterization of PABSA, an orally active and highly potent endothelin-receptor antagonist

Shimuta, S.I.; Barbosa, A.M.R.B.; Borges, A.C.R.; Paiva, T.B., 1999:
Pharmacological characterization of RMP-7, a novel bradykinin agonist in smooth muscle

Abe, Y.; Aoyagi, A.; Hara, T.; Abe, K.; Yamazaki, R.; Kumagae, Y.; Naruto, S.; Koyama, K.; Marumoto, S.; Tago, K.; Toda, N.; Takami, K.; Yamada, N.; Ori, M.; Kogen, H.; Kaneko, T., 2003:
Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease

Takahashi, M.; Taniguchi, T.; Tanaka, T.; Kanamaru, H.; Okada, K.; Muramatsu, I., 2003:
Pharmacological characterization of TA-0201, an endothelin receptor antagonist, with recombinant and human prostate endothelin receptors

Tsukada, J.; Tahara, A.; Tomura, Y.; Wada, K.I.hi; Kusayama, T.; Ishii, N.; Aoki, M.; Yatsu, T.; Uchida, W.; Taniguchi, N.; Tanaka, A., 2002:
Pharmacological characterization of YM471, a novel potent vasopressin V1A and V2 receptor antagonist

Rumsey, W.L.; Aharony, D.; Bialecki, R.A.; Abbott, B.M.; Barthlow, H.G.; Caccese, R.; Ghanekar, S.; Lengel, D.; McCarthy, M.; Wenrich, B.; Undem, B.; Ohnmacht, C.; Shenvi, A.; Albert, J.S.; Brown, F.; Bernstein, P.R.; Russell, K., 2001:
Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors

Bleakman, D.; Ogden, A.M.rie; Ornstein, P.L.; Hoo, K., 1999:
Pharmacological characterization of a GluR6 kainate receptor in cultured hippocampal neurons

Dorigo, P.; Floreani, M.; Santostasi, G.; Maragno, I.; Danieli-Betto, D.; Germinario, E.; Magno, S.M.; Primofiore, G.; Marini, A.M.; Da Settimo, F., 2000:
Pharmacological characterization of a new Ca(2+) sensitizer

Koss, M.C.; Yu, Y.; Hey, J.A.; Mcleod, R.L., 2002:
Pharmacological characterization of a noninvasive, chronic, experimental dog model of nasal congestion

Nakayama, Y.; Takano, Y.; Shimohigashi, Y.; Tanabe, S.; Fujita, T.; Kamiya, H.O.; Tsujimoto, G., 2000:
Pharmacological characterization of a novel AVP4-9 binding site in rat hippocampus

Woodward, D.F.; Krauss, A.H-P.; Chen, J.; Liang, Y.; Li, C.; Protzman, C.E.; Bogardus, A.; Chen, R.; Kedzie, K.M.; Krauss, H.A.; Gil, D.W.; Kharlamb, A.; Wheeler, L.A.; Babusis, D.; Welty, D.; Tang-Liu, D.D-S.; Cherukury, M.; Andrews, S.W.; Burk, R.M.; Garst, M.E., 2003:
Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024)

Chu, V.; Brown, K.; Colussi, D.; Gao, J.; Bostwick, J.; Kasiewski, C.; Bentley, R.; Morgan, S.; Guertin, K.; Pauls, H.W.; Gong, Y.; Zulli, A.; Perrone, M.H.; Dunwiddie, C.T.; Leadley, R.J., 2001:
Pharmacological characterization of a novel factor Xa inhibitor, FXV673

Umekawa, K.; Hasegawa, H.; Tsutsumi, Y.; Sato, K.; Matsumura, Y.; Ohashi, N., 2000:
Pharmacological characterization of a novel sulfonylureid-pyrazole derivative, SM-19712, a potent nonpeptidic inhibitor of endothelin converting enzyme

Poli, A.; Lucchi, R.; Notari, S.; Zampacavallo, G.; Gandolfi, O.; Traversa, U., 1999:
Pharmacological characterization of adenosine A1 receptors and its functional role in brown trout (Salmo trutta) brain

Bou, J.; Domenech, T.; Puig, J.; Heredia, A.; Gras, J.; Fernandez Forner, D.; Beleta, J.; Palacios, J.M., 2000:
Pharmacological characterization of almotriptan: An indolic 5-HT receptor agonist for the treatment of migraine

Shibano, M.; Yamamoto, Y.; Horinouchi, T.; Tanaka, Y.; Koike, K., 2002:
Pharmacological characterization of alpha1-adrenoceptor in mouse iliac artery

Ioudina, M.V.; Dyer, D.C., 2002:
Pharmacological characterization of alpha1-adrenoceptor subtypes in the bovine tail artery

Yamagishi, H.; Watanabe, M.; Yazaki, K.; Sawaki, K.; Kawaguchi, M., 2000:
Pharmacological characterization of an 18-kDa protein associated with the peripheral-type benzodiazepine receptor in salivary glands

Cohen, J.E.; Onyike, C.U.; McElroy, V.L.; Lin, A.H.; Abrams, T.W., 2003:
Pharmacological characterization of an adenylyl cyclase-coupled 5-HT receptor in aplysia: comparison with mammalian 5-HT receptors

Dutar, P.; Vu, H.M.; Perkel, D.J., 1999:
Pharmacological characterization of an unusual mGluR-evoked neuronal hyperpolarization mediated by activation of GIRK channels

Conklin, D.J.; Smith, M.P.; Olson, K.R., 1999:
Pharmacological characterization of arginine vasotocin vascular smooth muscle receptors in the trout (Oncorhynchus mykiss) in vitro

Silva, R.M.; Grossman, H.C.; Rossi, G.C.; Pasternak, G.W.; Bodnar, R.J., 2002:
Pharmacological characterization of beta-endorphin- and dynorphin A(1-17)-induced feeding using G-protein alpha-subunit antisense probes in rats

Bentley, K.R.; Jarrott, B., 2001:
Pharmacological characterization of bradykinin B1 and B2 receptors in IMR-90 and INT-407 human cell lines using a microphysiometer

Kubota, K.; Kubota-Watanabe, M.; Fujibayashi, K.; Saito, K., 1999:
Pharmacological characterization of capsaicin-induced body movement of neonatal rat

Hastings, N.B.; Orchinik, M.; Aubourg, M.V.; McEwen, B.S., 1999:
Pharmacological characterization of central and peripheral type I and type II adrenal steroid receptors in the prairie vole, a glucocorticoid-resistant rodent

Sato, T.; Morita, I.; Fujita, H.; Ono, M.; Kimishima, A.; Tomiyama, J.; Murota, S., 2001:
Pharmacological characterization of cepharanthin in chronic idiopathic thrombocytopenic purpura

Pusch, M.; Liantonio, A.; Bertorello, L.; Accardi, A.; D.L.ca, A.; Pierno, S.; Tortorella, V.; Camerino, D.C., 2000:
Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives

Holmberg, S.K.S.; Mikko, S.; Boswell, T.; Zoorob, R.; Larhammar, D., 2002:
Pharmacological characterization of cloned chicken neuropeptide Y receptors Y1 and Y5

Fujisaki, Yuko; Yamauchi, Atsushi; Shuto, Hideki; Niizeki, Midori; Makino, Kazutaka; Kataoka, Yasufumi; Oishi, Ryozo, 2001:
Pharmacological characterization of cyclosporine A-induced kaolin intake in rats

Inazu, M.; Kubota, N.; Takeda, H.; Zhang, J.; Kiuchi, Y.; Oguchi, K.; Matsumiya, T., 1999:
Pharmacological characterization of dopamine transport in cultured rat astrocytes

Sawada, H.; Endoh, M., 1999:
Pharmacological characterization of effects of UK-1745, a novel cardiotonic agent with beta-adrenoceptor-blocking action, in aequorin-loaded canine right ventricular muscle

Auld, D.S.; Day, J.C.; Mennicken, F.; Quirion, R., 2000:
Pharmacological characterization of endogenous acetylcholine release from primary septal cultures

Levan, T.D.; Babin, E.A.; Yamamura, H.I.; Bloom, J.W., 1999:
Pharmacological characterization of glucocorticoid receptors in primary human bronchial epithelial cells

Chattipakorn, S.C.; McMahon, L.L., 2002:
Pharmacological characterization of glycine-gated chloride currents recorded in rat hippocampal slices

Valentine, A.F.; Rizzo, C.A.; Rivelli, M.A.; Hey, J.A., 1999:
Pharmacological characterization of histamine H3 receptors in human saphenous vein and guinea pig ileum

Jensen, A.A.; Madsen, B.E.; Krogsgaard Larsen, P.; Brauner Osborne, H., 2001:
Pharmacological characterization of homobaclofen on wild type and mutant GABAB1b receptors coexpressed with the GABAB2 receptor

Mollereau, C.; Mazarguil, H.; Marcus, D.; Quelven, I.; Kotani, M.; Lannoy, V.; Dumont, Y.; Quirion, R.; Detheux, M.; Parmentier, M.; Zajac, J.M.rie, 2002:
Pharmacological characterization of human NPFF1 and NPFF2 receptors expressed in CHO cells by using NPY Y1 receptor antagonists

Lynch, D.R.; Shim, S.S.; Seifert, K.M.; Kurapathi, S.; Mutel, V.; Gallagher, M.J.; Guttmann, R.P., 2001:
Pharmacological characterization of interactions of RO 25-6981 with the NR2B (epsilon2) subunit

Smith, G.T.oy; Zakon, H.H., 2000:
Pharmacological characterization of ionic currents that regulate the pacemaker rhythm in a weakly electric fish

Dahlén, S.E., 2000:
Pharmacological characterization of leukotriene receptors

Phillips, M.; Wang, C.; Johnson, K.M., 2001:
Pharmacological characterization of locomotor sensitization induced by chronic phencyclidine administration

Schetz, J.A.; Kim, O-Jin.; Sibley, D.R., 2003:
Pharmacological characterization of mammalian D1 and D2 dopamine receptors expressed in Drosophila Schneider-2 cells

Ergun, H.; Ayhan, I.H.kki; Tulunay, F.C.nkat, 1999:
Pharmacological characterization of metamizol-induced relaxation in phenylephrine-precontracted rabbit thoracic aorta smooth muscle

Kaji, H.; Takii, Y.; Nishizawa, M.; Matsue, T., 2003:
Pharmacological characterization of micropatterned cardiac myocytes

Nirthanan, S.; Gao, R.; Gopalakrishnakone, P.; Gwee, M.C.E.; Khoo, H.E.; Cheah, L.S.; Manjunatha Kini, R., 2002:
Pharmacological characterization of mikatoxin, an alpha-neurotoxin isolated from the venom of the New-Guinean small-eyed snake Micropechis ikaheka

Zuckerman, A.; Bolan, E.; D.P.ulis, T.; Schmidt, D.; Spector, S.; Pasternak, G.W., 1999:
Pharmacological characterization of morphine-6-sulfate and codeine-6-sulfate

Gustafsson, H.; Afrah, A.; Brodin, E.; Stiller, C.O.av, 1999:
Pharmacological characterization of morphine-induced in vivo release of cholecystokinin in rat dorsal horn: Effects of ion channel blockers

Caccese, R.; Graham, A.; Bialecki, R., 2000:
Pharmacological characterization of mucin secretion from CHO-K1-hNK(1)R cells

Barras, M.; Coste, A.; Eon, M.-Therese; Guillot, E., 1999:
Pharmacological characterization of muscarinic receptors implicated in rabbit detrusor muscle contraction and activation of inositol phospholipid hydrolysis in rabbit detrusor and parotid gland

Damaj, M.I.; Slemmer, J.E.; Carroll, F.I.; Martin, B.R., 1999:
Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs

Damaj, M.I.; Glassco, W.; Dukat, M.; Martin, B.R., 1999 :
Pharmacological characterization of nicotine-induced seizures in mice

Lu, Y.; Grady, S.; Marks, M.J.; Picciotto, M.; Changeux, J.P.; Collins, A.C., 1998:
Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes

Rakhimov, M.R., 2000:
Pharmacological characterization of papain from papaya cultivated in Uzbekistan

D.B.cker, O.; Leclere, P.G.; Lefebvre, R.A., 2003:
Pharmacological characterization of pre- and postsynaptic prostanoid receptors in pig gastric fundus

Neumann, J.; Maas, R.; Bokník, P.; Jones, L.R.; Zimmermann, N.; Scholz, H., 1999:
Pharmacological characterization of protein phosphatase activities in preparations from failing human hearts

Lavoie, C.; Hébert, T.E., 2003:
Pharmacological characterization of putative beta1-beta2-adrenergic receptor heterodimers

Free, R.Benjamin.; von Fischer, N.D.; Boyd, R.Thomas.; McKay, D.B., 2003:
Pharmacological characterization of recombinant bovine alpha3beta4 neuronal nicotinic receptors stably expressed in HEK 293 cells

Bianchi, B.R.; Lynch, K.J.; Touma, E.; Niforatos, W.; Burgard, E.C.; Alexander, K.M.; Park, H.S.; Yu, H.; Metzger, R.; Kowaluk, E.; Jarvis, M.F.; Van Biesen, T., 1999:
Pharmacological characterization of recombinant human and rat P2X receptor subtypes

Jahn, O.; Eckart, K.; Sydow, S.; Hofmann, B.A.; Spiess, J., 2001:
Pharmacological characterization of recombinant rat corticotropin releasing factor binding protein using different sauvagine analogs

Fenik, P.; Veasey, S.C., 2002:
Pharmacological characterization of serotonergic receptor activity in the hypoglossal nucleus

Stevis, P.E.; Deecher, D.C.; Lopez, F.J.; Frail, D.E., 1999:
Pharmacological characterization of soluble human FSH receptor extracellular domain: facilitated secretion by coexpression with FSH

Chang, K.C.url; Kang, Y.J.n; Lee, Y.S.o; Chong, W.S.og; Yun Choi, H.S.ok; Lee, D.H.ong; Ryu, J.C.un, 1998:
Pharmacological characterization of synthetic tetrahydroisoquinoline alkaloids, YS 51 and YS 55, on the cardiovascular system

Beaujouan, J.C.aude; Saffroy, M.; Torrens, Y.; Sagan, S.; Glowinski, J., 1999:
Pharmacological characterization of tachykinin septide-sensitive binding sites in the rat submaxillary gland

Lograno, M.D.; Romano, M.R.saria, 2003:
Pharmacological characterization of the 5-HT1A, 5-HT2 and 5-HT3 receptors in the bovine ciliary muscle

Barton, M.E.; Klein, B.D.; Wolf, H.H.; White, H.S.eve, 2001:
Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy

Sundkvist, E.; Jaeger, R.; Sager, G., 2002:
Pharmacological characterization of the ATP-dependent low Km guanosine 3',5'-cyclic monophosphate (cGMP) transporter in human erythrocytes

Bailey, G.P.; Sewell, W.F., 2000:
Pharmacological characterization of the CGRP receptor in the lateral line organ of Xenopus laevis

Chu, J.; Wilczynski, W.; Wilcox, R.E., 2001:
Pharmacological characterization of the D1- and D2-like dopamine receptors from the brain of the leopard frog, Rana pipiens

Eschke, D.; Wüst, M.; Hauschildt, S.; Nieber, K., 2002:
Pharmacological characterization of the P2X(7) receptor on human macrophages using the patch-clamp technique

Ross, R.A.; Craib, S.J.; Stevenson, L.A.; Pertwee, R.G.; Henderson, A.; Toole, J.; Ellington, H.C., 2002:
Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide

Kassack, M., U.; Hoefgen, B.; Decker, M.; Eckstein, N.; Lehmann, J., 2002:
Pharmacological characterization of the benz(d)indolo(2,3-g)azecine LE300, a novel type of a nanomolar dopamine receptor antagonist

Mullins, D.E.; Guzzi, M.; Xia, L.; Parker, E.M., 2000:
Pharmacological characterization of the cloned neuropeptide Y y6 receptor

Brandsgaard, R.; Barrett, J.E.; Rosenzweig-Lipson, S., 2000:
Pharmacological characterization of the discriminative stimulus effects of the potassium channel blocker 4-aminopyridine in rats

Fantegrossi, W.E.; Godlewski, T.; Karabenick, R.L.; Stephens, J.M.; Ullrich, T.; Rice, K.C.; Woods, J.H., 2003:
Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice

Gasso, S.; Sunol, C.; Sanfeliu, C.; Rodriguez Farre, E.; Cristofol, R.M., 2000:
Pharmacological characterization of the effects of methylmercury and mercuric chloride on spontaneous noradrenaline release from rat hippocampal slices

Marteau, F.; Le Poul, E.; Communi, D.; Communi, D.; Labouret, C.; Savi, P.; Boeynaems, J-Marie.; Gonzalez, N.Suarez., 2003:
Pharmacological characterization of the human P2Y13 receptor

Kjølbye, A.Louise.; Knudsen, C.Boye.; Jepsen, T.; Larsen, B.Due.; Petersen, J.Søberg., 2003:
Pharmacological characterization of the new stable antiarrhythmic peptide analog Ac-D-Tyr-D-Pro-D-Hyp-Gly-D-Ala-Gly-NH2 (ZP123): in vivo and in vitro studies

Polidori, C.; Calo', G.; Ciccocioppo, R.; Guerrini, R.; Regoli, D.; Massi, M., 2000:
Pharmacological characterization of the nociceptin receptor mediating hyperphagia: Identification of a selective antagonist

Ciccocioppo, R.; Polidori, C.; Antonelli, L.; Salvadori, S.; Guerrini, R.; Massi, M., 2002:
Pharmacological characterization of the nociceptin receptor which mediates reduction of alcohol drinking in rats

Chiou, L.C., 2000:
Pharmacological characterization of the nociceptin receptor, ORL1. Insight from the inward rectifier activation in the periaqueductal gray

Dautzenberg, F.M.; Wichmann, J.; Higelin, J.; Py-Lang, G.; Kratzeisen, C.; Malherbe, P.; Kilpatrick, G.J.; Jenck, F., 2001:
Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo

Thomas, J.M.; Masgrau, R.; Churchill, G.C.; Galione, A., 2001:
Pharmacological characterization of the putative cADP-ribose receptor

Voehringer, C.; Reiser, G., 2001:
Pharmacological characterization of the rat brain P2Y1 receptor expressed in HEK293 cells: Ca2+ signaling and receptor regulation

D.C.lle, C.; Bessis, A.S.phie; Bockaert, J.; Acher, F.; Pin, J.P.ilippe, 2000:
Pharmacological characterization of the rat metabotropic glutamate receptor type 8a revealed strong similarities and slight differences with the type 4a receptor

Marazziti, D.; Baroni, S.; Rossi, A.; Masala, I.; Giannaccini, G.; Gori, V.; Lucacchini, A.; Cassano, G.B., 2001:
Pharmacological characterization of the serotonin transporter in young and elderly subjects

Eliasof, S.; Mcilvain, H.B.al; Petroski, R.E.; Foster, A.C.; Dunlop, J., 2001 :
Pharmacological characterization of threo-3-methylglutamic acid with excitatory amino acid transporters in native and recombinant systems

Hiraoka, Y.; Taniguchi, T.; Tanaka, T.; Okada, K.; Kanamaru, H.; Muramatsu, I., 2003:
Pharmacological characterization of unique prazosin-binding sites in human kidney

Szabo, T.; Biro, T.; Gonzalez, A.F.; Palkovits, M.; Blumberg, P.M., 2002:
Pharmacological characterization of vanilloid receptor located in the brain

Zhang, J.; Lipa, J.E.; Black, C.E.; Huang, N.; Neligan, P.C.; Ling, F.T.; Levine, R.H.; Semple, J.L.; Pang, C.Y., 2000:
Pharmacological characterization of vasomotor activity of human musculocutaneous perforator artery and vein

Park, Y-Su.; Yoo, S-Eun.; Shin, H-Sup.; Jin, Y-Ri.; Yun, Y-Pyo., 2003:
Pharmacological characterization of vasorelaxant effects of BMS-180448, a novel cardioselective ATP-sensitive potassium channel opener, in rat aorta

Zhao, H.; Poon, A.M.S.; Pang, S.F., 2000:
Pharmacological characterization, molecular subtyping, and autoradiographic localization of putative melatonin receptors in uterine endometrium of estrous rats

Bucinski, A.; Nasal, A.; Kaliszan, R., 2000:
Pharmacological classification of drugs based on neural network processing of molecular modeling data

Vogel, U.; Thein, N.; Moller, P.; Wallin, H., 2001:
Pharmacological coal tar induces G:C to T:A transversion mutations in the skin of mutaTM mouse

Glezer, S.; Finberg, J.P.M., 2003:
Pharmacological comparison between the actions of methamphetamine and 1-aminoindan stereoisomers on sympathetic nervous function in rat vas deferens

Takakura, K.; Muramatsu, I., 1999:
Pharmacological comparison between the nitrergic responses produced by intramural nerve stimulation and exogenous NO-donors in rat gastric fundus

Zhong, Yu; Dunn, Philip, M.; Burnstock, Geoffrey, 2000:
Pharmacological comparison of P2X receptors on rat coeliac, mouse coeliac and mouse pelvic ganglion neurons

Brady, C.A.; Stanford, I.M.; Ali, I.; Lin, L.; Williams, J.M.; Dubin, A.E.; Hope, A.G.; Barnes, N.M., 2001:
Pharmacological comparison of human homomeric 5-HT3A receptors versus heteromeric 5-HT3A/3B receptors

Yamaguchi, K.; Szlam, F.; Levy, J.H.; Makita, T., 2000:
Pharmacological comparison of human internal mammary artery and radial artery in terms of conduits for revascularization

Liu, Y.; Ren, G.; O'Rourke, B.; Marbán, E.; Seharaseyon, J., 2001:
Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels

Schioth, H.B.; Bouifrouri, A.A.; Rudzish, R.; Muceniece, R.; Watanobe, H.; Wikberg, J.E.S.; Larhammar, D., 2002:
Pharmacological comparison of rat and human melanocortin 3 and 4 receptors in vitro

Walter, R.; Mark, M.; Reinhart, W.H., 2000:
Pharmacological concentrations of arginine influence human whole blood viscosity independent of nitric oxide synthase activity in vitro

Sherman, D.L.; Keaney, J.F.; Biegelsen, E.S.; Duffy, S.J.; Coffman, J.D.; Vita, J.A., 2000:
Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension

Tesarik, J.; Nagy, P.; Abdelmassih, R.; Greco, E.; Mendoza, C., 2002:
Pharmacological concentrations of follicle-stimulating hormone and testosterone improve the efficacy of in vitro germ cell differentiation in men with maturation arrest

Buxbaum, J.D.; Cullen, E.I.; Friedhoff, L.T., 2002:
Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta-amyloid peptide in vitro and in patients

Amsden, Guy, W., 1999:
Pharmacological considerations in the emergence of resistance

Maulik, S.K.; Maulik, M., 2001:
Pharmacological control of cough

Kjellberg, F.; Tramer, M.R., 2001:
Pharmacological control of opioid-induced pruritus: A quantitative systematic review of randomized trials

Warrens, A.N., 2002:
Pharmacological control of the immune response in renal transplantation

Kintz, P.; Cirimele, V.; Ludes, B., 2000:
Pharmacological criteria that can affect the detection of doping agents in hair

Schang, L.M.; Bantly, A.; Knockaert, M.; Shaheen, F.; Meijer, L.; Malim, M.H.; Gray, N.S.; Schaffer, P.A., 2002:
Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins

Allouche, S.; Hasbi, A.; Ferey, V.; Sola, B.; Jauzac, P.; Polastron, J., 2000:
Pharmacological delta1- and delta2-opioid receptor subtypes in the human neuroblastoma cell line SK-N-BE: no evidence for distinct molecular entities

Vianna, M.R.M.; Barros, D.M.; Silva, T.; Choi, H.; Madche, C.; Rodrigues, C.; Medina, J.H.; Izquierdo, I., 2000:
Pharmacological demonstration of the differential involvement of protein kinase C isoforms in short- and long-term memory formation and retrieval of one-trial avoidance in rats

Spanswick, V.J.; Cummings, J.; Ritchie, A.A.; Smyth, J.F., 1998:
Pharmacological determinants of the antitumour activity of mitomycin C

Ravasi, S.; Capra, V.; Panigalli, T.; Rovati, G.E.rico; Nicosia, S., 2002:
Pharmacological differences among CysLT1 receptor antagonists with respect to LTC4 and LTD4 in human lung parenchyma

Belz, Gustav, G., 2001:
Pharmacological differences among angiotensin II receptor antagonists

Bruess, M.; Molderings, G.J.; Boenisch, H.; Goethert, M., 1999:
Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells

Truong, A.; Xing, X.; Forsayeth, J.R.; Dwoskin, L.P.; Crooks, P.A.; Cohen, B.N., 2001:
Pharmacological differences between immunoisolated native brain and heterologously expressed rat alpha4beta2 nicotinic receptors

Vianna, M.R.; Izquierdo, L.A.; Barros, D.M.; de Souza, M.M.; Rodrigues, C.; Sant'Anna, M.K.; Medina, J.H.; Izquierdo, I., 2001:
Pharmacological differences between memory consolidation of habituation to an open field and inhibitory avoidance learning

Jordan, R.; Mascelli, M.A., 1999:
Pharmacological differentiation of GP IIb/IIIa inhibitors

Thomas, N.K.; Hawkins, L.M.; Miller, J.C.; Troop, H.M.; Roberts, P.J.; Jane, D.E., 1998:
Pharmacological differentiation of kainate receptors on neonatal rat spinal motoneurones and dorsal roots

Uhlin, M.; Masucci, M.G.; Levitsky, V., 2003:
Pharmacological disintegration of lipid rafts decreases specific tetramer binding and disrupts the CD3 complex and CD8 heterodimer in human cytotoxic T lymphocytes

Cicala, C.; Morello, S.; Santagada, V.; Caliendo, G.; Sorrentino, L.; Cirino, G., 2001:
Pharmacological dissection of vascular effects caused by activation of protease-activated receptors 1 and 2 in anesthetized rats

Menzel, R.; Heyne, A.; Kinzel, C.; Gerber, B.; Fiala, A., 1999:
Pharmacological dissociation between the reinforcing, sensitizing, and response-releasing functions of reward in honeybee classical conditioning

Bonfante Cabarcas, R.; Bravo, I.; Nello, C.; Gutierrez Reyes, E.; Dos Santos, N.E.L.ureiro; Moreno Yanes, J.A., 2002:
Pharmacological doses of Zn2+ induce a muscarinic cholinergic supersensitivity

Sato, S.; Ohtake, A.; Matsushima, H.; Saitoh, C.; Usuda, S.; Miyata, K., 2001:
Pharmacological effect of tamsulosin in relation to dog plasma and tissue concentrations: prostatic and urethral retention possibly contributes to uroselectivity of tamsulosin

Kurata, K.; Y.Y.ng; Kinoshita, K.; Koyama, K.; Takahashi, K.; Tai, T., 1999:
Pharmacological effect on anti-emetic Chinese traditional prescriptions

Giada, F.; Conte, R.; Palatini, P., 1999:
Pharmacological effects and toxicity of anabolic steroids

Watanabe, K.; Matsunaga, T.; Nakamura, S.; Kimura, T.; Ho, I.K.; Yoshimura, H.; Yamamoto, I., 1999:
Pharmacological effects in mice of anandamide and its related fatty acid ethanolamides, and enhancement of cataleptogenic effect of anandamide by phenylmethylsulfonyl fluoride

Gates, M.; Ogden, A.; Bleakman, D., 2001:
Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro

Chen, C.F.; Chiou, W.F.i; Chou, C.J.n; Liao, J.F.i; Lin, L.C.wen; Wang, G.J.ne; Ueng, Y.F.ng, 2002:
Pharmacological effects of Evodia rutaecarpa and its bioactive components

Murakami, S.; Yoshida, M.; Iwashita, H.; Otani, M.; Miyamae, K.; Masunaga, K.; Miyamoto, Y.; Inadome, A.; Ueda, S., 2003:
Pharmacological effects of KRP-197 on the human isolated urinary bladder

Komatsu, Y.; Inoue, Y.; Goto, Y.; Fukazawa, T.; Hayashi, H., 1999:
Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban

Seegers, B.A.; Andriessen, M.P.; van Hooijdonk, C.A.; de Bakker, E.S.; van Vlijmen-Willems, I.M.; Parker, G.L.; van Erp, P.E.; van de Kerkhof, P.C., 2000:
Pharmacological effects of a specific leukotriene B(4) receptor antagonist (VML 295) on blood leukocytes, cutaneous inflammation and epidermal proliferation

Ichikawa, K.; Kojima, M., 2001:
Pharmacological effects of cabergoline against parkinsonism

Leal-Cardoso, J.H.; Fonteles, M.C., 1999:
Pharmacological effects of essential oils of plants of the northeast of Brazil

Naguib, M.; Hammond, D.L.; Schmid, P.G.; Baker, M.T.; Cutkomp, J.; Queral, L.; Smith, T., 2003:
Pharmacological effects of intravenous melatonin: comparative studies with thiopental and propofol

Ishikawa, H.; Yoshitomi, T.; Mashimo, K.; Nakanishi, M.; Shimizu, K., 2002:
Pharmacological effects of latanoprost, prostaglandin E2, and F2alpha on isolated rabbit ciliary artery

Meng, Yun; Dukat, Margozata; Bridgen, D.T.oyu; Martin, Billy, R.; Lichtman, Aron, H., 1999:
Pharmacological effects of methamphetamine and other stimulants via inhalation exposure

Kim, K.W.; Son, Y.; Shin, B.S.; Cho, K.P., 2001 :
Pharmacological effects of naltriben as a ligand for opioid mu and kappa receptors in rat cerebral cortex

Lee, J.-Ah; Jung, S.-Hee; Bae, M.-Kyung; Ryu, C.-Kyu; Lee, J.-Young; Chung, J.-Ho; Kim, H.-Jung, 2000:
Pharmacological effects of novel quinone compounds, 6-(fluorinated-phenyl)amino-5,8-quinolinediones, on inhibition of drug-induced relaxation of rat aorta and their putative action mechanism

Wu, C-Lung.; Hung, C-Road.; Chang, F-Young.; Pau, K-Y.Francis.; Wang, P.S., 2003:
Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats

Lo, M.J.; Wang, S.W.; Kau, M.M.; Chen, J.J.; Chen, Y.H.; Fang, V.S.; Ho, L.T.; Wang, P.S., 1998:
Pharmacological effects of propylthiouracil on corticosterone secretion in male rats

Yoshida, N., 1999:
Pharmacological effects of the gastroprokinetic agent mosapride citrate

Ali, S.-Abid; Hamid, F.; Abbasi, A.; Zaidi, Z., H.; Shehnaz, D., 1999:
Pharmacological effects of the leaf-nosed viper snake (Eristocophis macmahoni) venom and its HPLC fractions

Yamaguchi, K.; Yashita, T.; Nagase, T.; Kato, M.; Shimizu, M.; Takahashi, T.; Takahashi, K., 1999:
Pharmacological effects of three products of Chinese herbal remedies on experimental osteoporosis induced by ovariectomy in rats

Yono, M.; Yoshida, M.; Wada, Y.; Kikukawa, H.; Takahashi, W.; Inadome, A.; Seshita, H.; Ueda, S., 1999:
Pharmacological effects of tolterodine on human isolated urinary bladder

Lauta, Vito Michele, 2000:
Pharmacological elements in clinical application of synthetic peptides

Erhardt, S.; Oberg, H.; Mathe, J.M.; Engberg, G., 2001:
Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons

Ripps, H.; Qian, H.; Zakevicius, J., 2002:
Pharmacological enhancement of hemi-gap-junctional currents in Xenopus oocytes

Hart, A.M.kay; Wiberg, M.; Terenghi, G., 2002:
Pharmacological enhancement of peripheral nerve regeneration in the rat by systemic acetyl-L-carnitine treatment

Sun, M.K.; Alkon, D.L., 2001:
Pharmacological enhancement of synaptic efficacy, spatial learning, and memory through carbonic anhydrase activation in rats

Piruzyan, L.A.; Mikhailovskii, E.M., 2003:
Pharmacological ethnic metabolic safety: Communication I

Hillaire-Buys, D.; Shahar, L.; Fischer, B.; Chulkin, A.; Linck, N.; Chapal, J.; Loubatieres-Mariani, M.M.; Petit, P., 2001:
Pharmacological evaluation and chemical stability of 2-benzylthioether-5'-O-(1-thiotriphosphate)-adenosine, a new insulin secretagogue acting through P2Y receptors

Katsifis, A.; Mardon, K.; Mattner, F.; Loc'h, C.; Mcphee, M., E.; Dikic, B.; Kassiou, M.; Ridley, D., D., 2003:
Pharmacological evaluation of (S)-8-(123I)iodobretazenil: A radioligand for in vivo studies of central benzodiazepine receptors

Rahman, S.; Hasnat, A.; Hasan, C.M.; Rashid, M.A.; Ilias, M., 2001:
Pharmacological evaluation of Bangladeshi medicinal plants: A review

Kassiou, M.; Bottlaender, M.; Loc'h, C.; Dolle, F.; Musachio, J.L.; Coulon, C.; Ottaviani, M.; Dannals, R.F.; Maziere, B., 2002:
Pharmacological evaluation of a Br-76 analog of epibatidine: a potent ligand for studying brain nicotinic acetylcholine receptors

Talaga, P.; Matagne, A.; Klitgaard, H. , 2001:
Pharmacological evaluation of a diarylmethylene-piperidine derivative: A new potent atypical antipsychotic?

Vanover, K.E.; Robledo, S.; Huber, M.; Carter, R.B., 1999:
Pharmacological evaluation of a modified conflict procedure: Punished drinking in non-water-deprived rats

Sugiyama, A.; Takehana, S.; Hashimoto, K., 1999:
Pharmacological evaluation of a new laser blood flowmeter for measuring coronary blood flow, assessed in the canine isolated, blood-perfused ventricular tissue preparation in comparison with an electromagnetic flowmeter

Lichtman, A.H.; Peart, J.; Poklis, J.L.; Bridgen, D.T.oy; Razdan, R.K.; Wilson, D.M.; Poklis, A.; Meng, Y.; Byron, P.R.; Martin, B.R., 2000:
Pharmacological evaluation of aerosolized cannabinoids in mice

Fulton, D.; Mcgiff, J.C.; Quilley, J., 1998:
Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart

O'Neill, A.B.; Pan, J.B.; Sullivan, J.P.; Brioni, J.D., 1999:
Pharmacological evaluation of an in vivo model of vestibular dysfunction in the rat

Crombet, T.; Torres, L.; Neninger, E.; Catalá, M.; Solano, Mía.E.; Perera, A.; Torres, O.; Iznaga, N.; Torres, F.; Pérez, R.; Lage, Aín., 2003:
Pharmacological evaluation of humanized anti-epidermal growth factor receptor, monoclonal antibody h-R3, in patients with advanced epithelial-derived cancer

Guillon, J.; Levasseur, V.; Sonnet, P.; Stiebing, S.; Boulouard, M.; Dallemagne, P.; Quermonne, M.A.ne; Rault, S., 1999:
Pharmacological evaluation of new baclofen derivatives

Sivakumar, R.; Gnanasam, S.K.shore; Ramachandran, S.; Leonard, J.T.omas, 2002:
Pharmacological evaluation of some new 1-substituted-4-hydroxyphthalazines

Narendar, P.; Parthiban, J.; Anbalagan, N.; Gunasekaran, V.; Thomas Leonard, J., 2003:
Pharmacological evaluation of some new 2-substituted pyridine derivatives

Ravlee, I.; Sivakumar, R.; Muruganantham, N.; Anbalagan, N.; Gunasekaran, V.; Leonard, J.T.omas, 2003:
Pharmacological evaluation of some new 6-amino/methyl pyridine derivatives

Nagao, T., 1999:
Pharmacological evaluation of the development candidate

Dogne, J.M.; De-Leval, X.; Kolh, P.; Sanna, V.; Rolin, S.; Michaux, C.; Mauer, M.; David, J.L.; Masereel, B.; Pirotte, B., 2003:
Pharmacological evaluation of the novel thromboxane modulator BM-567 (I/II). Effects of BM-567 on platelet function

De-Leval, X.; Benoit, V.; Delarge, J.; Julemont, F.; Masereel, B.; Pirotte, B.; Merville, M.P.; David, J.L.; Dogne, J.M., 2003:
Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation

Poonyachoti, S.; Portoghese, P.S.; Brown, D.R., 2001:
Pharmacological evidence for a 7-benzylidenenaltrexone-preferring opioid receptor mediating the inhibitory actions of peptidic delta- and mu-opioid agonists on neurogenic ion transport in porcine ileal mucosa

Russ, U.; Rauch, U.; Quast, U., 1999:
Pharmacological evidence for a KATP channel in renin-secreting cells from rat kidney

Katsuta, K.; Umemura, K.; Ueyama, N.; Matsuoka, N., 2003:
Pharmacological evidence for a correlation between hippocampal CA1 cell damage and hyperlocomotion following global cerebral ischemia in gerbils

Guimaraes, A.P.ula C.; Prado, W.A., 1999:
Pharmacological evidence for a periaqueductal gray-nucleus raphe magnus connection mediating the antinociception induced by microinjecting carbachol into the dorsal periaqueductal gray of rats

Spadari-Bartfisch, R.C.; Santos, I.N.; Vanderlei, L.C.; Marcondes, F.K., 1999:
Pharmacological evidence for beta2-adrenoceptor in right atria from stressed female rats

Adami, M.; Coruzzi, G.; Sotirov, E.; Bertini, S.; Soldani, G., 2003:
Pharmacological evidence for beta3 adrenoceptors in the control of rat gastric acid secretion

Ekblad, Eva, 1999:
Pharmacological evidence for both neuronal and smooth muscular PAC1 receptors and a VIP-specific receptor in rat colon

Gupta, S.K.; Pillarisetti, K.; Thomas, R.A.; Aiyar, N., 2001:
Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1alpha: implications for development of selective CXCR4 antagonists

Nishimaru, K.; Tanaka, Y.; Tanaka, H.; Shigenobu, K., 2003:
Pharmacological evidence for involvement of phospholipase D, protein kinase C, and sodium-calcium exchanger in alpha-adrenoceptor-mediated negative inotropy in adult mouse ventricle

Ortiz, M.I.; Torres Lopez, J.E.; Castaneda Hernandez, G.; Rosas, R.; Vidal Cantu, G.C.; Granados Soto, V., 2002:
Pharmacological evidence for the activation of K+ channels by diclofenac

Stone, E.A.; Lin, Y.; Itteera, A.; Quartermain, D., 2001:
Pharmacological evidence for the role of central alpha 1B-adrenoceptors in the motor activity and spontaneous movement of mice

Cui, J.; Kulagina, N.V.; Michael, A.C., 2001:
Pharmacological evidence for the selectivity of in vivo signals obtained with enzyme-based electrochemical sensors

Davis, K.A.; Young, E.D., 2000 :
Pharmacological evidence of inhibitory and disinhibitory neuronal circuits in dorsal cochlear nucleus

Orsini, C.; Castellano, C.; Cabib, S., 2001:
Pharmacological evidence of muscarinic-cholinergic sensitization following chronic stress

Keedy, M.; Yorgey, N.; Hilty, J.; Price, A.; Hassenzahl, D.; Kuruvilla, H., 2003:
Pharmacological evidence suggests that the lysozyme/PACAP receptor of Tetrahymena thermophila is a polycation receptor

Pelleymounter, M.Ann.; Joppa, M.; Ling, N.; Foster, A.C., 2002:
Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress

Wrenn, C.C.; Crawley, J.N., 2001:
Pharmacological evidence supporting a role for galanin in cognition and affect

Coitinho, A.S.; de Mello, C.F.; Lima, T.T.; de Bastiani, J.; Fighera, M.R.; Wajner, M., 2001:
Pharmacological evidence that alpha-ketoisovaleric acid induces convulsions through GABAergic and glutamatergic mechanisms in rats

Willems, E.W.; Trion, M.; D.V.ies, P.; Heiligers, J.P.C.; Villalon, C.M.; Saxena, P.R., 1999:
Pharmacological evidence that alpha1- and alpha2-adrenoceptors mediate vasoconstriction of carotid arteriovenous anastomoses in anaesthetized pigs

Gonzalez Mariscal, G.; Melo, A.I.; Parlow, A.F.; Beyer, C.; Rosenblatt, J.S., 2000:
Pharmacological evidence that prolactin acts from late gestation to promote maternal behaviour in rabbits

Tanaka, Y.; Akutsu, A.; Tanaka, H.; Horinouchi, T.; Tsuru, H.; Koike, K.; Shigenobu, K., 2003:
Pharmacological evidence that tetraethylammonium-sensitive, iberiotoxin-insensitive K+ channels function as a negative feedback element for sympathetic neurotransmission by suppressing omega-conotoxin-GVIA-insensitive Ca2+ channels in the relaxation of rabbit facial vein

McGuire, D.; Marder, K., 2000:
Pharmacological frontiers in the treatment of AIDS dementia

Valdecantos, P.; Briones, R.; Moya, P.; Germain, A.; Huidobro Toro, J.P., 2003:
Pharmacological identification of P2X1, P2X4 and P2X7 nucleotide receptors in the smooth muscles of human umbilical cord and chorionic blood vessels

Devlin, C.L.ah; Schlosser, W.; Belz, D., T.; Kodiak, K.; Nash, R., F.; Zitomer, N., 2000:
Pharmacological identification of acetylcholine receptor subtypes in echinoderm smooth muscle (Sclerodactyla briareus)

Zhu, Z.T.o; Shen, K.Z.ong; Johnson, S.W., 2002:
Pharmacological identification of inward current evoked by dopamine in rat subthalamic neurons in vitro

Marinelli, S.; Bernardi, G.; Giacomini, P.; Mercuri, N.B., 2000:
Pharmacological identification of the K+ currents mediating the hypoglycemic hyperpolarization of rat midbrain dopaminergic neurones

Willems, E.W.; Valdivia, L.F.lipe; Ramirez San Juan, E.; Saxena, P.R.; Villalon, C.M., 2001:
Pharmacological identification of the major subtypes of adrenoceptors involved in the canine external carotid vasoconstrictor effects of adrenaline and noradrenaline

Dallegri, F.; Ottonello, L., 2002:
Pharmacological implications in the switch from acute to chronic inflammation

Taylor, G.P.; Lyall, E.G.H.; Back, D.; Ward, C.; Tudor Williams, G., 2000:
Pharmacological implications of lengthened in-utero exposure to nevirapine

Giannattasio, C.; Failla, M.; Calchera, I.; Grieco, N.; Scandola, L.; Grappiolo, A.; Mancia, G., 1999:
Pharmacological improvement of large arteries properties

Pean, C.; Wijkhuisen, A.; Djedaini Pilard, F.; Fischer, J.; Doly, S.; Conrath, M.; Couraud, J.Y.es; Grassi, J.; Perly, B.; Creminon, C., 2001:
Pharmacological in vitro evaluation of new substance P-cyclodextrin derivatives designed to drug targeting towards NK1-receptor bearing cells

Martin, J.H.; Ghez, C., 1999:
Pharmacological inactivation in the analysis of the central control of movement

Kempf, H.; Linares, C.; Corvol, P.; Gasc, J.M., 1998:
Pharmacological inactivation of the endothelin type A receptor in the early chick embryo: a model of mispatterning of the branchial arch derivatives

German, D.C.; Liang, C.L.; Manaye, K.F.; Lane, K.; Sonsalla, P.K., 2000:
Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons

Dobretsov, S.V.; Qian, P-Yuan., 2003:
Pharmacological induction of larval settlement and metamorphosis in the blue mussel Mytilus edulis L

Wei, H.; Kemp, S.; Mcguinness, M.C.; Moser, A.B.; Smith, K.D., 2000:
Pharmacological induction of peroxisomes in peroxisome biogenesis disorders

Udayakumar, T.S.; Bair, E.L.; Nagle, R.B.; Bowden, G.Timothy., 2003:
Pharmacological inhibition of FGF receptor signaling inhibits LNCaP prostate tumor growth, promatrilysin, and PSA expression

Choo, E.F.; Leake, B.; Wandel, C.; Imamura, H.; Wood, A.J.; Wilkinson, G.R.; Kim, R.B., 2000:
Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes

Sizemore, N.; Cox, A.D.; Barnard, J.A.; Oldham, S.M.; Reynolds, E.R.; Der, C.J.; Coffey, R.J., 1999:
Pharmacological inhibition of Ras-transformed epithelial cell growth is linked to down-regulation of epidermal growth factor-related peptides

Kern, T.S.; Engerman, R.L., 2001:
Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin

Li, J.N.; Gorospe, M.; Chrest, F.J.; Kumaravel, T.S.; Evans, M.K.; Han, W.F.; Pizer, E.S., 2001:
Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53

Finney, R.E.; Nudelman, E.; White, T.; Bursten, S.; Klein, P.; Leer, L.L.; Wang, N.; Waggoner, D.; Singer, J.W.; Lewis, R.A., 2000:
Pharmacological inhibition of phosphatidylcholine biosynthesis is associated with induction of phosphatidylinositol accumulation and cytolysis of neoplastic cell lines

Zhu, G.H.; Wong, B.C.Y.; Eggo, M.C.; Yuen, S.T.; Lai, K.C.; Lam, S.K., 1999:
Pharmacological inhibition of protein kinase C activity could induce apoptosis in gastric cancer cells by differential regulation of apoptosis-related genes

Penn, R.B.; Parent, J.L.c; Pronin, A.N.; Panettieri, R.A.Jr.; Benovic, J.L., 1999:
Pharmacological inhibition of protein kinases in intact cells: Antagonism of beta adrenergic receptor ligand binding by H-89 reveals limitation of usefulness

Hentzer, M.; Givskov, M., 2003:
Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections

Calabresi, P.; Marfia, G.A.; Amoroso, S.; Pisani, A.; Bernardi, G., 1999:
Pharmacological inhibition of the Na(+)/Ca(2+) exchanger enhances depolarizations induced by oxygen/glucose deprivation but not responses to excitatory amino acids in rat striatal neurons

English, J.M.; Cobb, M.H., 2002:
Pharmacological inhibitors of MAPK pathways

Dai, Y.; Yu, C.; Singh, V.; Tang, L.; Wang, Z.; McInistry, R.; Dent, P.; Grant, S., 2001:
Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells

Weizman, R.; Getslev, V.; Pankova, I.A.; Schrieber, S.; Pick, C.G., 1999:
Pharmacological interaction of the calcium channel blockers verapamil and flunarizine with the opioid system

Paoletti, R.; Corsini, A.; Bellosta, S., 2002:
Pharmacological interactions of statins

Peiro, C.; Vallejo, S.; Nevado, J.; Angulo, J.; Llergo, J.L.; Cercas, E.; Rodriguez Manas, L.; Sanchez Ferrer, C.F., 1999:
Pharmacological interference of vascular smooth muscle cell hypertrophy induced by glycosylated human oxyhaemoglobin

Habisch, H-Jörg.; Gorren, A.C.F.; Liang, H.; Venema, R.C.; Parkinson, J.F.; Schmidt, K.; Mayer, B., 2003:
Pharmacological interference with dimerization of human neuronal nitric-oxide synthase expressed in adenovirus-infected DLD-1 cells

Maleszka, R.; Helliwell, P.; Kucharski, R., 2000:
Pharmacological interference with glutamate re-uptake impairs long-term memory in the honeybee, Apis mellifera

Suleymanov, O.D.; Szalony, J.A.; Salyers, A.K.; LaChance, R.M.; Parlow, J.J.; South, M.S.; Wood, R.S.; Nicholson, N.S., 2003:
Pharmacological interruption of acute thrombus formation with minimal hemorrhagic complications by a small molecule tissue factor/factor VIIa inhibitor: comparison to factor Xa and thrombin inhibition in a nonhuman primate thrombosis model

Orth, S.R.; Schömig, M.; Ritz, E., 2001:
Pharmacological intervention in progressive renal diseases

Becker, G.J.; Perkovic, V.; Hewitson, T.D., 2001 :
Pharmacological intervention in renal fibrosis and vascular sclerosis

Compston, J.E., 2000:
Pharmacological interventions for post-menopausal osteoporosis: An evidence-based approach

Peeters-Scholte, C.; van den Tweel, E.; Ioroi, T.; Post, I.; Braun, K.; Veldhuis, W.; Nicolay, K.; Groenendaal, F.; van Bel, F., 2002:
Pharmacological interventions in the newborn piglet in the first 24 h after hypoxia-ischemia. A hemodynamic and electrophysiological perspective

Bhattacharya, R.; Rao, P.V.L.kshmana, 2001:
Pharmacological interventions of cyanide-induced cytotoxicity and DNA damage in isolated rat thymocytes and their protective efficacy in vivo

Urenjak, J.; Obrenovitch, T.P., 2000:
Pharmacological investigation into the involvement of nitric oxide in K+-induced cortical spreading depression

Scanlon, J.M.; Brocard, J.B.; Stout, A.K.; Reynolds, I.J., 2000:
Pharmacological investigation of mitochondrial ca(2+) transport in central neurons: studies with CGP-37157, an inhibitor of the mitochondrial Na(+)-Ca(2+) exchanger

Stummann, T.C.; Poulsen, Jørgen.H.; Hay-Schmidt, A.; Grunnet, M.; Klaerke, D.A.; Rasmussen, H.B.; Olesen, Søren-Peter.; Jorgensen, N.K., 2003:
Pharmacological investigation of the role of ion channels in salivary secretion

Janaki, S.; Vijayasekaran, V., 2000:
Pharmacological investigations on Aglaia roxburghiana (W and A) Miq. Var. Beddomei leaves

Gaillard, P.J.; D.B.er, A. (Bert) G.; Breimer, D.D., 2003:
Pharmacological investigations on lipopolysaccharide-induced permeability changes in the blood-brain barrier in vitro

Smirnov, S.; Paalasmaa, P.; Uusisaari, M.; Voipio, J.; Kaila, K., 1999:
Pharmacological isolation of the synaptic and nonsynaptic components of the GABA-mediated biphasic response in rat CA1 hippocampal pyramidal cells

Back, D.J., 1999:
Pharmacological issues relating to viral resistance

Hecker, J.R.; Snellgrove, C.A., 2003:
Pharmacological management of Alzheimer's disease

Hohnloser, S.H.; Li, Y.G.; Bender, B.; Grönefeld, G., 2000:
Pharmacological management of atrial fibrillation: an update

Moran, J.A.; Street, P.R.; Rogerson, J.W., 2001:
Pharmacological management of benign prostatic hypertrophy and prostate cancer in older men

Ebeling, Peter, R., 2000:
Pharmacological management of osteoporosis in 2000

Sandor, Paul, 2003:
Pharmacological management of tics in patients with TS

Zimmermann, J.S.; Kimmig, B., 1998:
Pharmacological manangement of acute radiation morbidity

Sedvall, G.C.; Karlsson, P., 1999:
Pharmacological manipulation of D1-dopamine receptor function in schizophrenia

Gysembergh, A.; Lemaire, S.; Piot, C.; Sportouch, C.; Richard, S.; Kloner, R.A.; Przyklenk, K., 1999:
Pharmacological manipulation of Ins(1,4,5)P3 signaling mimics preconditioning in rabbit heart

Benelli, A.; Bertolini, A.; Zoli, M.; Leo, G.; Filaferro, M.; Saltini, S.; Genedani, S., 2002:
Pharmacological manipulation of brain galaninergic system and sexual behavior in male mice

Briski, Karen, P., 1999:
Pharmacological manipulation of central nitric oxide/guanylate cyclase activity alters Fos expression by rat hypothalamic vasopressinergic neurons during acute glucose deprivation

Taback, S.P.; Guyda, H.J.; Van Vliet, G., 1999:
Pharmacological manipulation of height: qualitative review of study populations and designs

Corrigall, W.A.; Coen, K.M.; Zhang, J.; Adamson, L., 2002:
Pharmacological manipulations of the pedunculopontine tegmental nucleus in the rat reduce self-administration of both nicotine and cocaine

Brooks, D.P.; Ruffolo, R.R., 1999:
Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure

Griffiths, M.R.; Cooper, A.J.; Barber, D.J.; Mitchell, I.J., 2000:
Pharmacological mechanisms mediating phencyclidine-induced apoptosis of striatopallidal neurons: The roles of glutamate, dopamine, acetylcholine and corticosteroids

Martin-Aragón, S.; de las Heras, B.; Sanchez-Reus, M.I.; Benedi, J., 2001:
Pharmacological modification of endogenous antioxidant enzymes by ursolic acid on tetrachloride-induced liver damage in rats and primary cultures of rat hepatocytes

Weng, S.; Lauven, M.; Schaefer, T.; Polontchouk, L.; Grover, R.; Dhein, S., 2002:
Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation

Wartenberg, H.C.; Wartenberg, J.P.; Urban, B.W., 2003:
Pharmacological modification of sodium channels from the human heart atrium in planar lipid bilayers: electrophysiological characterization of responses to batrachotoxin and pentobarbital

Balati, B.; Varro, A.; Papp, J.G., 1999:
Pharmacological modification of the dispersion of repolarization in the heart: Importance of the M cells

Casal, J.A.; Corzo, M.D.; Pérez, L.F.; Alvarez, J.A.; Aldegunde, M.; Tutor, J.C., 2000:
Pharmacological modification of the serotonergic transmitter system and beta-N-acetylhexosaminidase activity in rats

Kitani, K.; Kanai, S.; Ivy, G.O.; Carrillo, M.C.istina, 1999:
Pharmacological modifications of endogenous antioxidant enzymes with special reference to the effects of deprenyl: A possible antioxidant strategy

Gallez, B.; Jordan, B.F.; Baudelet, C.; Misson, P.D.mien, 1999:
Pharmacological modifications of the partial pressure of oxygen in murine tumors: Evaluation using in vivo EPR oximetry

Dhein, S.; Polontchouk, L.; Salameh, A.; Haefliger, J.A.toine, 2002:
Pharmacological modulation and differential regulation of the cardiac gap junction proteins connexin 43 and connexin 40

Grunnet, M.; Jespersen, T.; Angelo, K.; Frokjaer Jensen, C.; Klaerke, D.A.; Olesen, S.P.ter; Jensen, B.S.aaning, 2001:
Pharmacological modulation of SK3 channels

Damazo, A.S.; Tavares, D.L.ma, W.; Perretti, M.; Oliani, S.M., 2001:
Pharmacological modulation of allergic inflammation in the rat airways and association with mast cell heterogeneity

Thiel, C.M.; Henson, R.N.; Morris, J.S.; Friston, K.J.; Dolan, R.J., 2001:
Pharmacological modulation of behavioral and neuronal correlates of repetition priming

Prete, S.P.; Cappelletti, D.; Baier, S.; Nasuti, P.; Guadagni, F.; D.V.cchis, L.; Greiner, J.W.; Bonmassar, E.; Graziani, G.; Aquino, A., 2002:
Pharmacological modulation of carcinoembryonic antigen in human cancer cells: studies with staurosporine

Chaves, F.; Leon, G.; Alvarado, V.-Hugo; Gutierrez, J.-Maria, 1998:
Pharmacological modulation of edema induced by Lys-49 and Asp-49 myotoxic phospholipases A2 isolated from the venom of the snake Bothrops asper (terciopelo)

Laight, D.W.; Kaw, A.V.; Carrier, M.J.; Anggård, E.E., 1998:
Pharmacological modulation of endothelial function by insulin in the rat aorta

Schulte, H.; Graven Nielsen, T.; Sollevi, A.; Jansson, Y.; Arendt Nielsen, L.; Segerdahl, M., 2003:
Pharmacological modulation of experimental phasic and tonic muscle pain by morphine, alfentanil and ketamine in healthy volunteers

Shiue, M.H.I.; Kulkarni, A.A.; Gukasyan, H.J.; Swisher, J.B.; Kim, K.J.n; Lee, V.H.L., 2000:
Pharmacological modulation of fluid secretion in the pigmented rabbit conjunctiva

Grechko, A.T.; Zelenin, K.N.; Bezhan, I.P.; Kalikhevich, V.N.; Ardemasova, Z.A.; Churkina, S.I., 1998:
Pharmacological modulation of group behavior and biorhythms during chronic experiment

Chacur, M.; Picolo, G.; Gutierrez, J.M.; Teixeira, C.F.P.; Cury, Y., 2001:
Pharmacological modulation of hyperalgesia induced by Bothrops asper (terciopelo) snake venom

Prause, O.; Laan, M.; Lötvall, J.; Lindén, A., 2003:
Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells

Koulen, P.; Thrower, E.C., 2002:
Pharmacological modulation of intracellular Ca(2+) channels at the single-channel level

Devor, D.C.; Bridges, R.J.; Pilewski, J.M., 2000:
Pharmacological modulation of ion transport across wild-type and DeltaF508 CFTR-expressing human bronchial epithelia

Blann, A.D.; Nadar, S.; Lip, G.Y.H., 2003:
Pharmacological modulation of platelet function in hypertension

Nguewa, P.A.; Fuertes, M.A.; Alonso, C.; Perez, J.M., 2003:
Pharmacological modulation of Poly(ADP-ribose) polymerase-mediated cell death: exploitation in cancer chemotherapy

Cunha, F.Q.; Teixeira, M.M.; Ferreira, S.H., 1999:
Pharmacological modulation of secondary mediator systems - cyclic AMP and cyclic GMP - on inflammatory hyperalgesia

Robe, P.A.ain; Princen, F.; Martin, D.; Malgrange, B.; Stevenaert, A.; Moonen, G.; Gielen, J.; Merville, M.P.ule; Bours, V., 2000:
Pharmacological modulation of the bystander effect in the herpes simplex virus thymidine kinase/ganciclovir gene therapy system: Effects of dibutyryl adenosine 3',5'-cyclic monophosphate, a-glycyrrhetinic acid, and cytosine arabinoside

Roshani, H.; Dabhoiwala, N.F.; Dijkhuis, T.; Pfaffendorf, M.; Boon, T.A.; Lamers, W.H., 2003:
Pharmacological modulation of ureteral peristalsis in a chronically instrumented conscious pig model. I: Effect of cholinergic stimulation and inhibition

Kochegarov, Andrei, A., 2003:
Pharmacological modulators of voltage-gated calcium channels and their therapeutical application

Kirwan, J.F.; Gouws, P.; Linnell, A.E.; Crowston, J.; Bunce, C., 2000:
Pharmacological mydriasis and optic disc examination

Schmidt, D.; Elger, C.; Holmes, G.L., 2002:
Pharmacological overtreatment in epilepsy: Mechanisms and management

Souza, L.C.; Campa, A., 1999:
Pharmacological parameters of intravenously administered amphotericin B in rats: comparison of the conventional formulation with amphotericin B associated with a triglyceride-rich emulsion

Wang, Q-Dong.; Pernow, J.; Sjöquist, P-Ove.; Rydén, L., 2002:
Pharmacological possibilities for protection against myocardial reperfusion injury

Gorba, T.; Allsopp, T.E., 2003:
Pharmacological potential of embryonic stem cells

Mtairag, E.Mostafa.; Houard, X.; Rais, S.; Pasquier, C.; Oudghiri, M.; Jacob, M-Paule.; Meilhac, O.; Michel, J-Baptiste., 2002:
Pharmacological potentiation of natriuretic peptide limits polymorphonuclear neutrophil-vascular cell interactions

Batthish, M.; Diaz, R.J.; Zeng, H-Ping.; Backx, P.H.; Wilson, G.J., 2002:
Pharmacological preconditioning in rabbit myocardium is blocked by chloride channel inhibition

Ito, K.; Ozasa, H.; Nagashima, Y.; Hagiwara, K.; Horikawa, S., 2001:
Pharmacological preconditioning with doxorubicin: Implications of heme oxygenase-1 induction in doxorubicin-induced hepatic injury in rats

Yang, C.W.; Ahn, H.J.; Han, H.J.; Kim, W.Y.; Li, C.; Shin, M.J.; Kim, S.K.; Park, J.H.; Kim, Y.S.; Moon, I.S.; Bang, B.K., 2001:
Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney

Piriou, V.; Chiari, P.; Lhuillier, F.; Bastien, O.; Loufoua, J.; Raisky, O.; David, J.S.; Ovize, M.; Lehot, J.J., 2002:
Pharmacological preconditioning: comparison of desflurane, sevoflurane, isoflurane and halothane in rabbit myocardium

Dao, H.Hao.; Essalihi, R.; Graillon, J-François.; Larivière, R.; D.C.amplain, J.; Moreau, P., 2002:
Pharmacological prevention and regression of arterial remodeling in a rat model of isolated systolic hypertension

Efimova, N.Iu.; Chernov, V.I.; Efimova, I.Iu.; Akhmedov, S.D.; Podoksenov, I.K.; Lishmanov, I.B., 2003:
Pharmacological prevention of cerebrovascular complications in cardiac patients after coronary artery bypass surgery

Tomiyama, Y.; Murakami, M.; Hayakawa, K.; Akiyama, K.; Yamazaki, Y.; Kojima, M.; Shibata, N.; Akahane, M., 2003:
Pharmacological profile of KUL-7211, a selective beta-adrenoceptor agonist, in isolated ureteral smooth muscle

Pruneau, D.; Paquet, J.L.c; Luccarini, J.M.chel; Defrene, E.; Fouchet, C.; Franck, R.M.rie; Loillier, B.; Robert, C.; Belichard, P.; Duclos, H.; Cremers, B.; Dodey, P., 1999:
Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist

Muratori, M.; Lippi, A.; Mancina, R.; Iafrate, E.M.; Cirillo, R.; Lopez, G.; Bigioni, M.; Maggi, M.; Criscuoli, M.; Maggi, C.A., 2003:
Pharmacological profile of MEN 11066, a novel potent and selective aromatase inhibitor

Cabre, F.; Carabaza, A.; Garcia, A.M.ria; Calvo, L.; Cucchi, P.; Palomer, A.; Pascual, J.; Garcia, M.L.uisa; Manzini, S.; Lecci, A.; Crea, A.; Maggi, C.A.berto, 2002:
Pharmacological profile of MEN91507, a new CysLT1 receptor antagonist

Takahashi, S.; Sonehara, K.; Takagi, K.; Miwa, T.; Horikomi, K.; Mita, N.; Nagase, H.; Iizuka, K.; Sakai, K., 1999:
Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors

Stean, T.O.; Hirst, W.D.; Thomas, D.R.; Price, G.W.; Rogers, D.; Riley, G.; Bromidge, S.M.; Serafinowska, H.T.; Smith, D.R.; Bartlett, S.; Deeks, N.; Duxon, M.; Upton, N., 2002:
Pharmacological profile of SB-357134: A potent, selective, brain penetrant, and orally active 5-HT6 receptor antagonist

Takagi, M.; Mochida, H.; Noto, T.; Yano, K.; Inoue, H.; Ikeo, T.; Kikkawa, K., 2001:
Pharmacological profile of T-1032, a novel specific phosphodiesterase type 5 inhibitor, in isolated rat aorta and rabbit corpus cavernosum

Naito, A.; Ohtake, Y.; Hasegaw, H.; Fukaya, A.Y.; Kurasawa, T.; Naito, K.; Matsukawa, H.; Oguma, T.; Ezure, Y.; Tsuriya, Y.; Tanaka, H.; Koike, K.; Shigenobu, K., 2000:
Pharmacological profile of VP-343, a novel selective vasopressin V2 receptor antagonist, in rats

Ito, H.; Kiso, T.; Miyata, K.; Kamato, T.; Yuki, H.; Akuzawa, S.; Nagakura, Y.; Yamano, M.; Suzuki, M.; Naitoh, Y.; Sakai, H.; Iwaoka, K.; Yamaguchi, T., 2000:
Pharmacological profile of YM-31636, a novel 5-HT3 receptor agonist, in vitro

Wilson, C.; Hunt, S.J.; Tang, E.; Wright, N.; Kelly, E.; Palmer, S.; Heys, C.; Mellor, S.; James, R.; Bialecki, R., 1999:
Pharmacological profile of ZD1611, a novel, orally active endothelin ETA receptor antagonist

Nagamine, J.; Nagata, R.; Seki, H.; Nomura-Akimaru, N.; Ueki, Y.; Kumagai, K.; Taiji, M.; Noguchi, H., 2001:
Pharmacological profile of a new orally active growth hormone secretagogue, SM-130686

Broqua, P.; Riviere, P.J-M.; Conn, P.Michael.; Rivier, J.E.; Aubert, M.L.; Junien, J-Louis., 2002:
Pharmacological profile of a new, potent, and long-acting gonadotropin-releasing hormone antagonist: degarelix

Kawabata, K.; Hagio, T.; Matsuoka, S., 2003:
Pharmacological profile of a specific neutrophil elastase inhibitor, Sivelestat sodium hydrate

Ito, S.; Sved, A.F., 2000:
Pharmacological profile of depressor response elicited by sarthran in rat ventrolateral medulla

Labeaga, L.; Orjales, A., 2000:
Pharmacological profile of dosmalfate

D.A.ici, M.; Dallanoce, C.; D.M.cheli, C.; Angeli, P.; Marucci, G.; Cantalamessa, F.; Sparapassi, L., 2000:
Pharmacological profile of enantiomerically pure chiral muscarinic agonists: Desoxymuscarines

Chiou, W.F.i; Chen, C.F., 2002:
Pharmacological profile of evodiamine in isolated rabbit corpus cavernosum

Camarda, V.; Rizzi, A.; Calo, G.; Guerrini, R.; Salvadori, S.; Regoli, D., 2002:
Pharmacological profile of hemokinin 1: A novel member of the tachykinin family

Satoh, S.I.hi; Utsunomiya, T.; Tsurui, K.; Kobayashi, T.; Ikegaki, I.; Sasaki, Y.; Asano, T., 2001:
Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage

Rogóz, Z.; Skuza, G.; Maj, J., 1999:
Pharmacological profile of milnacipran, a new antidepressant, given acutely

Tatsumi, M.; Jansen, K.; Blakely, R.D.; Richelson, E., 1999:
Pharmacological profile of neuroleptics at human monoamine transporters

Correia, N.A.; Oliveira, R.B.; Ballejo, G., 2000:
Pharmacological profile of nitrergic nerve-, nitric oxide-, nitrosoglutathione- and hydroxylamine-induced relaxations of the rat duodenum

Calo', G.; Rizzi, A.; Bigoni, R.; Guerrini, R.; Salvadori, S.; Regoli, D., 2002:
Pharmacological profile of nociceptin/orphanin FQ receptors

Tomura, Yuichi; Tahara, Atsuo; Tsukada, Junko; Yatsu, Takeyuki; Uchida, Wataru; IIzumi, Yuichi; Honda, Kazuo, 1999:
Pharmacological profile of orally administered YM087, a vasopressin antagonist, in conscious rats

Bucolo, C.; Maltese, A., 2002:
Pharmacological profile of oxaprozin eye drops

Jackson, C.V.; Bailey, B.D.; Shetler, T.J., 2000:
Pharmacological profile of recombinant, human activated protein C (LY203638) in a canine model of coronary artery thrombosis

Ergin, A.; Abaci, A.; Sakalli, A.; Eryol, N.K.mal; Oguzhan, A.; Unal, S.; Cetin, S., 1999:
Pharmacological profile of survivors of acute myocardial infarction at Turkish academic hospitals

Willems, E.W.; Valdivia, L.F.lipe; Saxena, P.R.; Villalon, C.M., 2001:
Pharmacological profile of the mechanisms involved in the external carotid vascular effects of the antimigraine agent isometheptene in anaesthetised dogs

Micheletti, R.; Mattera, G.G.; Rocchetti, M.; Schiavone, A.; Loi, M.F.; Zaza, A.; Gagnol, R.J.P.; D.M.nari, S.; Melloni, P.; Carminati, P.; Bianchi, G.; Ferrari, P., 2002:
Pharmacological profile of the novel inotropic agent (E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride (PST2744)

Goumain, M.; Voisin, T.; Lorinet, A.M.rie; Balasubramaniam, A.; Laburthe, M., 1998:
Pharmacological profile of the rat intestinal crypt peptide YY receptor vs. the recombinant rat Y5 receptor

Villalon, C.M.; Ramirez San Juan, E.; Sanchez Lopez, A.; Bravo, G.; Willems, E.W.; Saxena, P.R.; Centurion, D., 2003:
Pharmacological profile of the vascular responses to dopamine in the canine external carotid circulation

Ogawa, T.; Sugidachi, A.; Tanaka, N.; Fujimoto, K.; Asai, F., 2002:
Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptor antagonist R-102444

Shibata, T.; Matsui, K.; Nagao, K.; Shinkai, H.; Yonemori, F.; Wakitani, K., 1999:
Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivatives

Ishige, K.; Ito, Y.; Fukuda, H., 1998:
Pharmacological profiles of absence seizure-induced increases in CRE- and AP-1 DNA-binding activities in gamma-butyrolactone-treated mice

Adessi, Céline.; Frossard, M-José.; Boissard, C.; Fraga, S.; Bieler, S.; Ruckle, T.; Vilbois, F.; Robinson, S.M.; Mutter, M.; Banks, W.A.; Soto, C., 2003:
Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease

Chaturvedi, K.; Jiang, X.; Christoffers, K.H.; Chinen, N.; Bandari, P.; Raveglia, L.F.; Ronzoni, S.; Dondio, G.; Howells, R.D., 2000:
Pharmacological profiles of selective non-peptidic delta opioid receptor ligands

Kobayashi, M.; Naito, K., 2000:
Pharmacological profiles of the potent carbonic anhydrase inhibitor dorzolamide hydrochloride, a topical antiglaucoma agent